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  i 
ABSTRACT  
 
Background: Comprehensive HIV care aims at providing care and support, from HIV 
counselling and testing, through pre-antiretroviral (pre-ARV) care to antiretroviral 
therapy (ART). However, many people living with HIV (PLHIV) do not start treatment 
or are lost to follow-up during pre-ARV care, and subsequently initiate ART very late, 
with a high risk of HIV/AIDS-related mortality. Determinants of uptake/retention of 
PLHIV under pre-ARV care and delayed ART initiation in Uganda, where HIV and ART 
awareness are presumably high, are not sufficiently understood. 
Main aim: To investigate uptake and loss to follow-up of PLHIV under pre-ARV care 
and delayed ART initiation in order to inform policy and strategic planning for improved 
comprehensive HIV/AIDS care. 
Methods: Four studies (I-IV) were conducted in Iganga district, eastern Uganda. Study I 
used key informant interviews (KIIs) with five health workers and 10 in-depth interviews 
(IDIs) with PLHIV, as well as six focus group discussions (FGDs) with caretakers of the 
PLHIV to explore reasons for loss to follow-up under pre-ARV care. Study II was a 
randomised controlled trial involving 400 participants, to evaluate the effect of extended 
counselling on uptake of pre-ARV care. Study III used 20 IDIs with clients on ART and 
10 FGDs with caretakers of ART clients to understand reasons for delayed ART 
initiation. Study IV was a case-control study involving 152 cases (clients who initiated 
ART at CD4 < 50 cells/µl) and 202 controls (clients who initiated ART at CD4 50-200 
cells/µl) to assess risk factors for very late initiation of ART. Content analysis was used 
for qualitative data, and univariate, bivariate and multivariate analysis for quantitative 
data. 
Results: Reasons for dropping out of pre-ARV care included inadequate post-test 
counselling to PLHIV and competition from traditional/spiritual healers. Other reasons 
included transportation costs, long waiting time, lack of incentives to seek pre-ARV care 
by PLHIV who perceived themselves to be healthy, and gender inequality (I). PLHIV 
who underwent counselling by staff trained in basic counselling skills, combined with 
home visits by community network support agents, were 1.8 times more likely to take up 
pre-ARV care compared to PLHIV who received the standard care (RR 1.8; 95% CI 1.4-
  ii 
2.1) (II). ARV stock-outs, inadequate pre-ARV care and perceived lack of staff 
confidentiality were system barriers to timely ART initiation. Weak family/social support 
and misconceptions about ARVs were cited as individual/community barriers to timely 
ART initiation (III). Seeking care from traditional/spiritual healers before attending 
formal care (AOR 7.8; 95% CI 3.7-16.4), lack of pre-ARV care (AOR 4.6; 95% CI 2.3-
9.3), subsistence farming (AOR 6.3; 95% CI 3.1-13.0) and lack of family/social support 
(AOR 3.3; 95% CI 1.6-6.6) were crucial risk factors for very late ART initiation (IV). 
Higher age (AOR 0.9; 95% CI 0.8-0.9) and being female (AOR 0.4; 95% CI 0.2-0.8) 
were protective factors against very late initiation of ART (IV). 
Discussion: Adequate post-test counselling for newly diagnosed PLHIV, combined with 
follow-up care by network support agents, could help retain PLHIV under pre-ARV care 
and allow timely initiation of ART. Trained and supervised traditional/spiritual healers 
could complement government efforts in offering some components of pre-ARV care. 
ART services should be made more affordable, accessible and user-friendly to enhance 
timely ART initiation. Other system deficiencies, such as stock-outs of cotrimoxazole 
and ARVs and lack of adequate staff also need to be addressed. There is a need for social 
mobilisation to address gender inequality, stigma and misconceptions about ARVs and to 
boost social support for PLHIV.  
 
Key words: counselling, community support agents, pre-ARV care, traditional/spiritual 
healers, HIV, antiretroviral treatment, adherence, Uganda 
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PREFACE  
 
“Ondekeire abaana musengwa wange, singa wajja wanhwaku obulezi bwataso, tomanha 
walibaierewo” (You have left me with orphans my boss, if you had gone for treatment from the 
AIDS support organisation, maybe you would still be alive).  
This was the cry I heard from a middle-aged woman at the clinician’s office in the outpatients’ 
section when conducting an evening hospital round as Medical Superintendent of Iganga Hospital 
way back in 2006. The hospital was constructed in 1968 and is located 115 km east of the capital 
of Uganda, Kampala. Time check was 8.00 pm. The woman’s cry had attracted many people 
around the department. Outside the department was a motorcycle they had hired to bring the 
patient to the hospital from their home 50 km away.  
 
Inside the clinician’s office lay the body of a young man on a stretcher; he had clear signs of 
severe wasting. I looked straight into the clinician’s face. He looked sad and resigned. This same 
clinician also worked in the antiretroviral therapy (ART) clinic. He informed me that he vividly 
remembered having attended to the deceased some years back, in the pre-antiretroviral (pre-ARV) 
clinic, but that the deceased had most likely not returned for care since then.  
 
By the body sat an elderly woman, who I later found out was the mother of the deceased. With 
many reflections, I looked outside the window, and my eyes met a mixture of darkness and stars. I 
calmed the woman and talked to her, only to confirm that indeed the deceased had tested HIV- 
positive at Iganga Hospital years back, but chose to seek spiritual healing until this fateful day, 
when the pastor told them to go to hospital because the patient had been convulsing the whole 
day. I instructed the hospital administrator to organise some transport for the deceased to the 
burial site. 
 
As I drove back home, I wondered whether there was something we could have done earlier to 
follow-up this patient before this fateful day. The following morning, I invited the person in 
charge of the ART clinic for a chat. After a brief discussion and review of the pre-ART register, I 
realised that this was not an isolated case. Indeed, approximately 90% of the clients who were 
supposed to attend the pre-ARV clinic regularly had been lost to follow-up. This stimulated my 
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interest in looking at the ART register, only to discover that many of our clients in the ART clinic 
were cases of late diagnosis who had initiated ART when they had very low CD4 cell counts. 
These particular patients had not been attending the pre-ARV clinic either, but were 
coincidentally diagnosed through provider-initiated HIV counselling and testing on suspicion of 
AIDS.  
 
How, as overall supervisor of services at the facility, could I have allowed this to happen? I 
contemplatively looked outside the window of my office and convinced myself that it was not 
time to lament and blame anyone. The question in my mind was what can be done to ensure that 
people who test HIV-positive are regularly followed up so that they initiate ART on time?  
My efforts to contribute to answering this question is the focus of this thesis. 
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1.0 INTRODUCTION 
1.1 The HIV pandemic 
Globally the number of people living with HIV/AIDS (PLHIV) is estimated at 33.3 million 
people (31.4 - 35.3 million). Of these, 30.8 million are adults (15-45 years) and 2.5 million are 
children under 15 years of age. Women account for approximately 52% of the adult population 
living with HIV/AIDS. In 2009 the total number of people newly infected with HIV was 
approximately 2.6 million. By the end of 2009 sub-Saharan Africa (SSA), which has only 10% of 
the total global population, accounted for 22.5 million (68%) of all people living with HIV 
(PLHIV), 72% of AIDS deaths and 70% of all the new infections worldwide (UNAIDS, 2010). 
 
The pandemic is impeding economic development and has dramatically decreased the life 
expectancy in several African countries. It has also over-stretched the already weak health care 
systems in many resource-poor settings. HIV/AIDS is now well established on the list of the top 
five leading causes of death worldwide, and is responsible for one in every five deaths in SSA 
(Kumarasamy et al., 2007; UNAIDS, 2008a; World Health Organisation (WHO), 2003b; Piot et 
al., 2001; UNAIDS, 2010).  
 
The global response to the HIV pandemic includes prioritising HIV care among the Millennium 
Development Goals (MDGs 6a and b) adopted by world leaders in the year 2000. The sixth MDG 
aims to provide access to antiretroviral therapy (ART) to 50% of all those who need it and to have 
halted and begun to reverse the spread of HIV by 2015 (UNDP, 2010, UNDP, 2005). However, 
meeting this target, requires an effective and comprehensive HIV/AIDS response tailored to 
ensure universal access to HIV testing, prevention, care, treatment and support to PLHIV and 
their communities. The response therefore calls for a need to scale up HIV testing in order to 
identify all those in need of HIV treatment, and to strengthen the link between HIV diagnosis and 
comprehensive HIV/AIDS care, including timely initiation of ART.  
 
Although there has been an increase in access to voluntary counselling and testing (VCT) in SSA, 
only 10% of the adult population know their HIV sero status, leaving a high unmet need for HIV 
testing (UNAIDS, 2008). Most PLHIV in SSA remain undiagnosed and cannot therefore be 
linked to adequate prevention, treatment, care and support (UNAIDS, 2008b; Nakanjako et al., 
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2009). Even among those screened for HIV, however, many either do not take up comprehensive 
HIV care or get lost to follow-up in transition from testing HIV positive through pre-antiretroviral 
(pre-ARV) care to initiation of antiretroviral therapy (ART).  
 
The international standard aims at ongoing counselling and regular pre-ARV care for newly 
screened PLHIV at least once every six months (for WHO stage 1 and 2) if they have no 
complications. With the advent of cotrimoxazole prophylaxis to prevent opportunistic infections 
like Pneumocystis carinii pneumonia and others, however, the guidelines propose quarterly 
monitoring of PLHIV not yet eligible for ART if no clinical problems occur and they are taking 
the drugs correctly (WHO, 2006; Medscape, 2008; Wendo, 2005; Minstry of Health (MOH), 
2005a, 2006a). Regular pre-ARV care ensures that PLHIV are monitored to, among others, 
initiate ART on time. Available evidence indicates that regular pre-ARV care increases by three 
times the chances of initiating ART on time, with an average of 15 life years saved for those on 
treatment in the long run (MOH, 2004; Hallett et al., 2008; Nakanjako et al., 2009; UNAIDS, 
2009). 
 
Unfortunately, even in high-income countries up to 30% of PLHIV present late for HIV care, do 
not therefore benefit from the important regular pre-ARV care, and subsequently initiate ART late 
with a high risk of mortality. This proportion
 
is higher in low-income countries with weaker 
health systems (Battegay et al., 2008; Nakanjako et al., 2009; Smart, 2007b). In SSA up to 59% 
of PLHIV do not enrol or adhere to the continuum of comprehensive HIV care from VCT to pre-
ARV care to ART. Subsequently many PLHIV are not regularly monitored and initiate ART very 
late with a high risk of premature mortality (Long, 2008; Losina et al., 2010; Larson et al., 2010; 
Larsson et al., 2009; Tsague, 2008). 
 
Uganda has been heralded as a success story in the fight against HIV/AIDS, with apparently high 
HIV and ART awareness. The country has steered a course of a rapid increase of accredited sites 
offering ART, from 48 to 398 sites between 2003 and 2010 (Uganda AIDS Commission (UAC), 
2007; UAC, 2010b; UNAIDS, 2008a). However, the country still suffers with a low uptake and 
retention rate of PLHIV under pre-ARV care, and a large proportion of PLHIV initiating ART 
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very late (at CD4 counts below 50 cells/µl) with a much higher risk of early mortality (Lutalo et 
al., 2009; Smart, 2007b; Hammer et al., 2008; Kigozi et al., 2009a; UAC, 2008).   
 
Low uptake or loss to follow-up of newly screened PLHIV under pre-ARV care and delayed ART 
initiation are major challenges to scaling up access to comprehensive HIV care, especially when 
global efforts are being driven towards earlier ART initiation, already at a CD4 count of < 350 
cells/µl (Hammer et al., 2008; WHO, 2009b; WHO, 2009a). 
 
1.2 Country profile of Uganda 
Uganda has a projected population of 30.7 million people and an annual population growth rate of 
3.3%. The under-five mortality rate is currently 137 deaths per 1000 live births, while the infant 
mortality rate is 75/1000 live births. The maternal mortality ratio currently stands at 435/100 000 
live births (MOH, 2009) (Table 1).  
 
 




2002 2007 2009 
Population, total (millions) 24.2 28.4 30.7 
Population growth (annual %) 3.2 3.3 3.3 
Maternal mortality ratio (/100 000 live births) 505 435 435 
Infant mortality rate (/1000 live births) 88 76 76 
Adolescent pregnancy (%) 32 25 137 
ANC attendance (four visits, %) 42 47 47 
Deliveries by skilled attendant (%) 38 41 42 
Contraceptive prevalence rate (%) 22.8 23.7 24 
Unmet need for contraception 35 41 41 
Total fertility rate 6.9 6.7 6.3 
Literacy rate (%) 65 69 75 
Life expectancy  51 51 53 
Population below poverty line, < US$1 (%) 38 31 31 
Fully immunized 38 46 64 
No. of people living with HIV/AIDS 600 000 1 101 317 1 200 000 
HIV prevalence (%) 6.1 6.4 6.5 
New HIV infections - 110 694 120 000 
AIDS deaths   78 000 61 306 64 000 
Total need for ART 75 000 322 819 379 551 
Total receiving ART  - 153 718 220 139 
 
Source: UBOS, 2007/10; UNFPA, 2008/9; UNDP, 2009; MOH, 2010;UNICEF, 2010. 
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Approximately 1.2 million people in Uganda are HIV-infected. Women, urban dwellers and 
residents of the post-conflict northern Uganda region are disproportionately affected. Sexual 
transmission continues to contribute approximately 80% of new HIV infections, while mother-to- 
child transmission contributes approximately 20%. In 2009 an estimated  120 000 new HIV 
infections occurred and 64 000 people died from AIDS-related illnesses (UAC, 2010, UNAIDS, 
2010).  
 
Uganda has been able to increase HIV awareness and significantly reduce adult HIV prevalence, 
from a peak of 18% in 1992 to 6.4% in 2007 (UAC, 2007; UAC, 2008; UAC, 2010b; Uganda 
Bureau of Statisitics (UBOS), 2009). According to the MOH, 379 551 PLHIV (303 088 adults, 76 
463 children) are in need of ART in the country, based on a CD4 T-cell count cut-off of CD4 < 
200/μl for ART initiation. The figure increases to 540 094 PLHIV (463 344 adults, 76 750 
children) if the WHO-recommended ART eligibility criterion for ART initiation of CD4 < 350/μl 
is used. Based on the current number of active ART clients, the coverage of ART in the country is 
57.5% of eligible individuals (66% adults, 24% children) based on a CD4 < 200/μl. The coverage 
decreases to approximately 40% of eligible individuals (43% adults, 24% children) based on a 
CD4 <350/μl. Overall, only a fraction of facilities in the country prescribe ART, and this is 
mostly at hospitals and health centres at level IV (see below) (MOH, 2010).  
 
Delivery of health services in Uganda is under the stewardship of the MOH, which is responsible 
for mobilising resources and overall budgeting, policy formulation and regulation and policy 
dialogue with development partners. Other functions of the MOH include strategic planning, 
quality assurance, capacity development, technical support supervision and monitoring and 
evaluation of the overall sector performance. The delivery of services is provided by both the 
public and private sector. The private sector comprises of private not for profit organisations, 
private health practitioners and traditional and complementary medicine practitioners. The public 
sector is organised in a hierarchical order, as follows: the village level (level I), traditionally 
called village health teams; health centre level II, serving a parish; health centre III serving a 
subcounty; health centre IV serving a county (also called a health subdistrict); general hospitals 
serving one or more districts; regional referral hospitals, and national referral hospitals, which are 
self-accounting and autonomous institutions. The public sector services are based on providing a 
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minimum health care package which has been developed for every level of service delivery 
(Table 2), (MOH, 2009, MOH, 2005a). 
Table 2. The Uganda National Public Health System Structure. 
Health unit Physical structure Location Population 
Health centre I 
(village health 
teams) 
None Village 1000 
Health centre II Outpatient services (OPD)  Parish 5000 
Health centre IIII OPD, maternal, laboratory, general 
ward 
Subcounty 10 000 
Health centre IV OPD, maternal, laboratory, general 
ward, theatre, blood transfusion 
County 100 000 
General hospital Hospital, laboratory and X-ray  District 100 000-1 000 000 
Regional referral 
hospital 
Specialist services 3-5 districts 1-2 million 
National referral 
hospital 
Advanced tertiary care National >20 000 000 
Adapted from the Uganda MOH Health Sector Strategic Plan 2000/01-2004/05. 
 
1.3 The HIV epidemic response in Uganda 
 
Since the late 1980s Uganda has adopted an open and multisectoral nationwide response to the 
HIV epidemic. The UAC is mandated to oversee, plan and coordinate AIDS prevention and 
control activities throughout the country (UAC, 2007). In collaboration with other partners, the 
commission has been able to complete several policies to serve its mandate. Some of these 
include the National AIDS Policy, the cotrimoxazole prophylaxis policy, the ART policy and 
guidelines for HIV counselling and testing (HCT), prevention of mother-to-child transmission 
(PMTCT) and orphaned and vulnerable children services (UAC, 2010). There are also other 
complementary policies for delivery of appropriate HIV care in the country, such as the National 
Health Policy I and II and the Health Sector Strategic Plans I and II, (MOH, 2009, MOH, 2005a). 
 
The overall goal driving current HIV care activities in Uganda is to achieve universal access 
targets for HIV/AIDS prevention, care, treatment and social support by 2012. The goal will be 
attained through reducing the HIV incidence rate by 40% and improving the quality of life of 
PLHIV by mitigating the health effects of HIV/AIDS by 2012. Other strategies include reducing 
the social, cultural and economic effects of HIV/AIDS at individual, household and community 
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levels, and building an effective support system for quality, equitable and timely service delivery 
(UAC, 2010). Attaining this goal, however, calls for measures that would ensure timely and 
effective compliance to the domains of comprehensive HIV care and support (Hallett et al., 2008; 
Hammer et al., 2008; Nakanjako et al., 2009). 
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2.0 COMPREHENSIVE HIV/AIDS CARE AND SUPPORT 
 
Comprehensive HIV/AIDS care and support is a relatively new phenomenon in the management 
of HIV/AIDS. The care constitutes a systematic ladder of ascendance from HCT to pre-ARV care 
to ART. It is intended not only for PLHIV but also for all those directly affected by HIV 
(families, friends, children and those who provide care and support from the community). The 
service endeavours to respond to the holistic needs of PLHIV at all stages of HIV infection and 
attempts to slow progression and maintain the person at the highest functional level. Its component 
domains include provision of HCT, and clinical, psychosocial, nutritional, legal, economic, family 
social and community support for PLHIV. Appropriate care and support for HIV should involve 
the PLHIV themselves or those affected by HIV in the choice, design and delivery of the services. 
It should also ensure equitable access to the services, information about the services, and have 
respect for client autonomy (UCAID, 2008; UNAIDS et al., 2004; Ritzenthaler, 2005; Nakanjako 
et al., 2009; MOH, 2003a).  
 
2.1 HIV counselling and testing (HCT) 
 
HCT is the key entry-point to all HIV prevention, treatment, care and support services. Through 
HCT people discover their HIV status and its implications and make informed choices for their 
future life. HCT reduces the risk of acquiring or transmitting HIV through positive behavioural 
change. It also encourages disclosure and subsequent social support and reduces denial, stigma 
and discrimination. The counselling enables PLHIV to make informed decisions about family 
planning and promotes access to early medical care for opportunistic infections and sexually 
transmitted infections (STIs), (MOH, 2005b, UNAIDS, 1997). HCT can be client-initiated VCT 
or provider-initiated HIV counselling and testing (PIHCT).  
 
VCT is an HIV-prevention intervention initiated by the client at his or her free will. It provides 
the opportunity for the client to confidentially explore and understand his/her HIV risks and to 
learn his/her HIV infection status with the support of a counsellor. VCT can be done in areas with 
no physical structure (free-standing). It may also be health unit-based or through outreach 
services such as home-based care. Either way, however, there must an appropriate referral system 
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for the client to access other components of comprehensive HIV care once they test HIV-positive 
(MOH, 2005b). 
 
Provider-initiated counselling (PIHCT) is the routine testing of patients provided and initiated by 
a health provider. It can be diagnostic in clients who need an HIV test for medical reasons 
because the patient presents with symptoms that may be attributable to HIV or has an illness 
associated with HIV. PIHCT can also be done through routine counselling and testing. Routine 
counselling and testing is offered as part of the clinical evaluation of all patients in settings where 
HIV is prevalent. It constitutes “opt-in” where an HIV test is routinely recommended and offered 
to each patient and the patient explicitly consents to receive the HIV test. It may also be “opt-out” 
where  an HIV test is routinely recommended and provided to  each patient and the patient is 
informed of his/her right to refuse the test. In certain circumstances, such as tissue donation and 
medicolegal circumstances such as rape and defilement, however, HIV testing can be mandatory 
and may be done regardless of consent (MOH, 2005b). 
 
Ideally, newly screened PLHIV should be enrolled for pre-ARV care. Unfortunately, most PLHIV 
are not aware of their HIV status. In SSA only about 12% of men and 10% of women know their 
HIV status (UNAIDS, 2010). In Uganda, data from a national sero-behavioural survey showed 
that only 15% of the adult population is aware of their HIV sero status (MOH, 2006).  
 
Some of the identified barriers or motivators for uptake of VCT include age, high education and 
knowledge about HIV (Sherr et al., 2007). Others are occupation, transportation difficulties, 
health status, ethnicity, high-risk behaviour, perceiving oneself as low risk, fear of unsolicited 
disclosure, fear of stigma and discrimination, male gender, having more than one sexual partner 
within the past 6 months, being married and using alcohol (Ma et al., 2007; Rou et al., 2009). 
Recent developments in the area of cotrimoxazole prophylaxis, tuberculosis preventive therapies 
and PMTCT have focused attention on expanding access to VCT as a vital component of 
comprehensive HIV care (Taegtmeyer, 2004, WHO/UNAIDS, 2005, RTI, 2010, UNAIDS, 2001). 
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2.2 Pre-Antiretroviral (Pre-ARV) care 
  
Pre-ARV care is given to PLHIV before they are eligible for ART. It constitutes psychosocial 
support, nutritional care, ongoing counselling, cotrimoxazole prophylaxis to prevent opportunistic 
infections and routine monitoring of PLHIV to assess their eligibility for ART (MOH, 2003, 
MOH, 2004, Losina et al., 2010). PLHIV should access this service through quarterly visits and 
clinical check-ups at health facilities (Hallett et al., 2008, Losina et al., 2010). Although the global 
proportion of PLHIV under pre-ARV care is not comprehensively documented, UNAIDS 
estimates that 15% of all PLHIV have AIDS and are hence eligible for ART. By implication 
therefore 85% (28.3 million) of all PLHIV are supposed to be under pre-ARV care (UNAIDS, 
2010). Few of them, however, enrol and adhere to the continuum of pre-ARV care, and loss to 
follow-up is high, especially in SSA (UNAIDS, 2009). Consequently, many PLHIV lost to 
follow-up do not benefit from the public health advantages this care is meant to provide.  
 
2.3 Antiretroviral therapy (ART) 
 
ART involves the use of at least three ARV drugs to maximally suppress HIV and stop 
progression of HIV disease in PLHIV. Huge reductions have been seen in rates of death and 
suffering when use is made of a potent ARV regimen among PLHIV (WHO, 2010). In 2009 5.2 
million (36%) of the approximately 15 million people who needed ART in low- and middle- 
income countries worldwide received it. This in effect means 9.8 million PLHIV in need of ART 
in these countries could not access ART (UNAIDS, 2010).  
 
In Uganda it is recommended to initiate ART in adults and adolescents with documented HIV 
infection and; CD4 cell count of 250 cells/ μl and below or CD4 cell count above 250 but below 
350 cells/ μl in those who are co-infected with tuberculosis (TB), or WHO Stage III disease and  
women who are pregnant. Clients with WHO Stage IV disease irrespective of CD4 cell count or 
WHO stage I or II with CD4 cell counts are also recommended to initiate ART (MOH, 2003, 
WHO, 2003a, MOH, 2008). Recently, however, the WHO in a rapid advice report recommended 
ART initiation for PLHIV at CD4 cell counts of <350/μl (WHO, 2009a). However, because of 
inadequate drugs and supplies and an already over-stretched health system, the Uganda 
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government still uses the 2008 treatment guidelines that provide for initiation of ART at CD4 cell 
counts of <250/μl (Nakanjako et al., 2009, MOH, 2010).  
The recent WHO guidelines from 2010 on the threshold for ART initiation (CD4< 350/μl) will 
increase even further the number of PLHIV requiring ART, especially in resource-poor settings 
(UN, 2010, WHO, 2009a). The new recommendation also raises the debate on whether PLHIV 
who initiate ART at a CD4 cell count of <250/μl should be labelled as timely or late ART 
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Source:  WHO, 2008. 
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2.4 Health system components and functions 
The WHO defines a health system as all the activities whose primary purpose is to promote, 
restore or maintain the health of the people. The six building blocks of a health system include 
service delivery, human resources for health, health care financing, drugs and supplies, health 
management information systems and leadership and governance (WHO, 2011b). A good health 
system should be able to deliver quality services to all people when and where they need them, 
although the specific configuration of services may vary from country to country. Such a system 
would require adequate health care financing, well-trained and adequately paid workers and a 
reliable information management system for decision-making and policy formulation and 
regulation. In addition, good leadership and governance, well maintained facilities, equipment, 
drugs and supplies and logistics are needed to deliver quality health care (WHO, 2011b).  
2.4.1 Health system challenges in Uganda  
 
Like many resource-poor settings, Uganda faces multiple challenges in her endeavour to deliver 
health services including comprehensive HIV care to the population. The main challenges of the 
Uganda health system are scarcity of human resources for health, lack of infrastructure and 
equipment, poor health care financing and inadequate drugs and supplies to meet client demands. 
 
Human resources for health  
Trained and skilled staff are vital in delivering comprehensive health care. However, in Uganda 
human resources for health are too scarce to meet the service demands, leading to a heavy 
workload on those who are available. A report by the Uganda MOH indicates that by November 
2008, only 51% of approved positions had been filled at national level. The scarcity of health 
personnel is more critical in conflict, post-conflict, rural and hard to reach areas.  
 
This sector in Uganda is also characterised by insufficient training capacity for health workers 
with the right mixture of skills to meet the needs of the people, low remuneration and poor 
working conditions. In addition, health workers are inequitably distributed, with many preferring 
to work in urban areas. Many health workers have also migrated to other countries in search of 
attractive salaries and opportunities. Absenteeism, dualism and the poor attitude of health workers 
towards patients is a common reality in many government units (MOH, 2009, UAC, 2010). 
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Health infrastructure 
In Uganda the current population living within 5 km of a health facility, including both public and 
private units, is 72% (MOH, 2009). However, many government facilities lack appropriate 
equipment and are in a state of disrepair. The hospitals are congested with few beds, and in such 
facilities floor cases are numerous. There has been little rehabilitation of buildings and 
maintenance of medical equipment at all levels of service delivery. Most facilities in the rural and 
hard to reach areas lack accommodation for staff making it hard to attract the desired personnel. 
The functionality of the health system with regard to infrastructure in Uganda is therefore a 
challenge, and systems strengthening will be required - especially at district level - to effectively 
deliver comprehensive HIV care among others (MOH, 2009). 
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Table 4. Coverage of ART services by level of facility in Uganda, September 2009. 
 
Health facility level Total No. of 
facilities 
No. of facilities 
providing ART 
% 
National referral hospitals  2 2 100 
Regional referral hospitals 11 11 100 
General hospitals 98 98 100 
Health centre IV 166 130 78 
Health centre III 905 40 4 
Health centre II 1887 2 0.1 
Research programmes N/A 4  
Specialised clinics N/A 31  
Private for profit clinics Unknown 52  
Total  374  
N/A = not applicable. Source: MOH, 2009. 
 
Drugs and supplies 
A good health care system should be able to deliver adequate quantities of affordable, good- 
quality essential drugs and supplies to all those who need them (WHO, 2011a). In Uganda 
approximately 70% of government health units have monthly stock-outs of any indicator 
medicine. In addition, only 30% of the essential medical health supplies are provided for in the 
national budget (MOH, 2009). Global initiatives remain the basic providers of resources needed 
for malaria, HIV/AIDS, TB, vaccines and reproductive health commodities. During the financial 
year 2006/7, for example, the contribution from global initiatives was US $2.39 per capita out of 
the total US $4.00  per capita spent on the above services (MOH, 2009). Clients who can afford to 
do so therefore resort to the private sector for essential medical and health supplies, in spite of the 
high costs. About 90% of all medicines are imported. Counterfeit drugs are also becoming an 
increasing problem in Uganda, especially in the private for profit sector (MOH, 2009).  
 
The MOH attributes stock-outs to extensive institutional arrangements, overload of the national 
medical stores, inadequate financing and delayed and incomplete reporting, which makes 
quantification of the desired drugs and supplies difficult (UAC, 2010, MOH, 2010).  
  15  
 
Funding for health care 
Uganda’s health expenditure as a proportion of the government’s discretionary expenditure has 
remained relatively stable at 9.6%, still below the Abuja Declaration target of 15% (MOH, 2009, 
UBOS, 2009). Although the private sector charges user fees, there is no user fee for public lower-
level health units and general wings of publicly owned hospitals. Health insurance is a preserve of 
the lucky few and is subsidised by employers on behalf of their employees (MOH, 2009). 
 
Most costs for health care in Uganda (50%) are incurred by households out of pocket, followed by 
donors (35%) and then Government (15%). Financing has been largely inadequate to enable 
provision of the Uganda National Minimum Health Care Package at almost all levels of service 
delivery. For example, while the MOH anticipated per capita costs for 2011/2012 to be US $47.9, 
the Medium-term Expenditure Framework for the same period is estimated at US $12.5 - a 
shortfall of almost US $29 (MOH, 2009). A recent study in Uganda showed that while recurrent 
expenditure on primary health care had increased by almost 70 times in the last 10 years, key 
aspects that would facilitate its realisation were not addressed (Mugisha and Nabyonga-Orem, 
2010). There is a need therefore for an optimal balance in investment in the different inputs to 
ensure efficiency in health spending. In view of the low health expenditure per capita, inadequate 
human resources, inadequate drugs and supplies and limited health infrastructure, there is a need 
to adopt community-oriented access approaches that will deliver comprehensive HIV care to 
those who need it. 
 
2.5 Uptake of pre-antiretroviral care  
 
Research has been done on barriers to uptake of ART in resource-poor settings. Identified barriers 
to uptake of ART in such settings include cost, food insufficiency, distance to clinic, women’s 
lack of decision-making power, stigma, poverty, fear of medication, lack of information and 
belief in traditional medicine (Mshana et al., 2006, Wilson and Blower, 2007, Muula et al., 2007, 
Unge et al., 2008, Plummer et al., 2006). However, little is known about barriers to uptake of pre-
ARV care, and the socio-contextual and policy issues for pre-ARV care may be different from 
those for ART. Pre-ARV clients are, for example, likely to be physically strong and going about 
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their work normally compared to ART-eligible clients. They may not therefore perceive 
themselves as being susceptible to any danger if they do not take up pre-ARV care, contrary to 
ART-eligible clients who are likely to be sick enough to warrant health care-seeking. 
2.5.1 Loss to follow-up of PLHIV under pre-ARV 
 
Retention of PLHIV under comprehensive HIV care is a vital strategy for the overall management 
of PLHIV (UNAIDS, 2010). Unfortunately, many PLHIV are lost to follow-up during HIV care, 
especially during pre-ARV care in SSA (Long, 2008, Losina et al., 2010, Larson et al., 2010). In 
Uganda, maintenance of care and retention of clients under comprehensive HIV care is still 
minimal since follow-up is still very low, except where there are network support agents for 
PLHIV (MOH, 2010). The network support agents have remained active, especially in places 
where civil society organisations have strong partnerships with the health facilities to provide 
both counselling and general HIV/AIDS care at facility level, and in the communities (MOH, 
2010, UAC, 2010). 
 
A lot of research has been done on barriers to retention and adherence to ART in both high and 
low income settings (Ezzy et al., 1998, Hardon et al., 2007, Unge et al., 2010, Nakanjako et al., 
2009, Alice Nakiyemba et al., 2004). Some of the barriers identified by these studies include 
young age, low education status, financial constraints, weak health care infrastructure, few and 
poorly trained health staff, pervasive stigma, lack of social support, lack of harm reduction 
protocols and poor supply of drugs. Others include co-morbidities, fatigue, hunger, waiting time 
and transport costs, drug side-effects, failure to carry drugs on travel, poverty, beliefs, fear of 
side-effects, religious practices and negative attitudes from religious leaders. However, little is 
known about reasons for loss to follow-up of PLHIV under pre-ARV, especially in the context of 
Uganda where HIV and ART awareness are presumed to be high.  
2.5.2 Delayed initiation of antiretroviral therapy 
 
Delayed initiation of ART for PLHIV is a major concern, especially at a time when WHO is 
advocating for earlier ART initiation at a CD4 cell count of <350 cells/µl (Hammer et al., 2008, 
Sterne et al., 2009, WHO, 2009a). Delayed initiation of ART is associated with late-stage 
diagnosis and results in high rates of HIV-related morbidity and mortality (WHO, 2009b). In 
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SSA, while the overall coverage of ART initiation has increased to 37% of those in need, 
emerging evidence shows that up to 59% of PLHIV in SSA are either lost to follow-up or start 
ART at a very late stage of the disease (UNAIDS, 2010, Tsague, 2008).  
 
Recent studies also show that 40% of PLHIV in Uganda present for HIV care late or very late, at 
WHO disease stages III or IV, many with CD4 cell counts of <50 cells/µl (Smart, 2007, Kigozi et 
al., 2009, Battegay et al., 2008). The Ugandan HIV/AIDS National Strategic Plan 2007/8 – 
2011/12 projected an increase in ART coverage to about 80% by 2011/12. However, limited 
uptake of and delayed access to HIV services are still a major stumbling block to reaching these 
targets (UAC, 2007). There is a paucity of information on why PLHIV would initiate ART very 
late in a country where HIV and ART awareness are presumably high (UAC, 2007).  
 
2.6 Role of low-cost interventions in comprehensive HIV care 
 
Because of poverty and a limited health infrastructure for increasing access to the rural poor and 
most vulnerable, many multilateral organisations and health programmes such as UNICEF/WHO 
have advocated for an integrated community case approach for fevers in children in order to reach 
the poor (Bryce et al., 2008, WHO/UNICEF, 2004). Programmes such as the integrated 
community case management for malaria and the home-based management of fever have 
produced increased access to treatment for malaria and/or pneumonia (Winch et al., 2005, 
Nsungwa-Sabiiti et al., 2007, Haines et al., 2007). 
 
Smilarly, home-based care programmes for HIV/ART piloted in many resource-poor settings 
have also shown increased uptake, high retention rates for HIV care and increased adherence to 
ART (Weidle Paul J et al., 2006). The use of peripheral units and trained, supervised lay workers 
to provide ART services in Uganda has, for example, made the services more affordable, 
accessible,  and attractive to PLHIV (Jaffar, 2009, Jaffar et al., 2005, Maskew et al., 2007). 
Although these pilot studies have been conducted in highly funded environments, their success 
gives the impetus to a trial of low-cost interventions tailored to optimal use of the available 
resources, as long as they increase access to comprehensive HIV care. Community health workers 
  18  
or network support agents for HIV care, for example, provide a pool of trainable and supervised 
volunteers for increasing access to comprehensive HIV care (MOH, 2010, UAC, 2007).  
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3.0 THEORETICAL FRAMEWORK FOR COMPREHENSIVE HIV CARE  
 
HIV/AIDS is a condition characterised by stigma, self-denial, discrimination and a great need for 
family and community social support. Furthermore, the condition requires behavioural change for 
the PLHIV to access prevention, care and support services. To adhere to the continuum of 
comprehensive HIV care, PLHIV require physical, spiritual, moral, logistical, financial and 
material support from their intimate partners, immediate family, close relatives, employers and 
other social networks to enable them overcome barriers or challenges to seeking or accessing 
appropriate care. In addition, there must be enabling policies and guidelines to address the socio-
contextual aspects of HIV care and support to positively influence the desired behaviour change 
(UAC, 2007, URCS., 2008, Population-Council., 2010, Avert, 2010, IFRCRCS, 2010, UNAIDS, 
2001, Feucht et al., 2007, Birbeck et al., 2009, Lieber et al., 2006). 
 
Research has shown that individuals’ choices are influenced by many factors acting at different 
levels, ranging from the intrapersonal and interpersonal to the community and society in general 
(Fleury and Lee, 2006, Facoine P and Facoine N, 2007). Any successful intervention in care and 
support for PLHIV must therefore take into consideration the interrelated levels of influence 
which go beyond the individual PLHIV, but also the health care delivery system and their 
environment (DiClemente et al., 2004, DiClemente et al., 2005, Campbell et al., 2007, Sallis JF 
and Owen N, 2002, CARE, 2010). All these concepts, which are vital to this thesis, are well 
defined by the socio ecological model (SEM), which we used to define and discuss client and 
system determinants for pre-ARV care and ART initiation. 
3.1 The socio ecological model 
 
The socio-ecological model (SEM) is based on the intertwined relationship between the 
individual and the environment (Sallis JF and Owen N, 2002, Moore, 2001). The model caters for 
the multiple levels of influence for behaviour change and actions including intrapersonal 
(biological, psychological), interpersonal (social, cultural, attitudinal), organisational, community, 
physical environmental and policy outlines or guidelines. It therefore offers an explicit direction 
guiding the development of more comprehensive population-wide interventions. The model also 
recognises that behaviour change is expected to be maximised when environments and policies 
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support healthful choices, when social norms and social support for healthful choices are strong 
and when individuals are motivated and educated to make those choices (McMurray, 2006). More 
importantly, the model can be used to develop comprehensive intervention approaches that 
systematically target mechanisms of change at each level of influence (Stokols et al., 1996, Fleury 
and Lee, 2006, McLeroy et al., 1988, Moore, 2001).  
 
This thesis uses the SEM to explore reasons for loss to follow-up of PLHIV from pre-ARV care 
(paper I) and very late initiation of ART (paper III) with regard to the policy, the views of 
PLHIV, their families, social networks and the community in which they live. The thesis also 
evaluates the effect of modified policy guidelines complemented by a community component on 
uptake of pre-ARV care (paper II), and assesses crucial risk factors for very late initiation of ART 
(paper IV), based on individual, community and policy-guided variables.  
 
  
Figure 1. A multiple-level schematic drawing of the SEM (Modified from Sallis and Owen, 2002).  
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4.0 RATIONALE FOR THE STUDIES 
 
Uganda has been heralded as a success story in the fight against AIDS, having adopted an early, 
open and multisectoral national response to the HIV epidemic. This response has increased HIV 
awareness and contributed to the significant reductions seen in adult HIV prevalence, from a peak 
of 18% in 1992 to 6.4% in 2007. However, reports about Uganda indicate that in spite of these 
achievements, a large proportion of PLHIV (90%) in some districts either do not take up or are 
lost to follow-up during pre-ARV care, and consequently many PLHIV initiate ART very late (at 
a CD4 count below 50 cells/µl), with a much higher risk of early mortality (Lutalo et al., 2009, 
Smart, 2007, Kigozi et al., 2009, DHO, 2009). Failure to take up or loss to follow up of PLHIV 
during pre-ARV care and very late ART initiation are major barriers to scaling up access to ART 
in Uganda, especially when global efforts are being driven towards earlier ART initiation, already 
at a CD4 count of < 350 cells/µl (Hammer et al., 2008, WHO, 2009a). 
 
There is little information on reasons for failure to take up or loss to follow-up of PLHIV during 
pre-ARV care and barriers to or motivators for very late initiation of ART in the context of 
Uganda, where HIV and ART awareness are presumably high. Available literature captures 
determinants for uptake of VCT, ART and non-adherence to ART in low- and high-income 
countries (Kumarasamy et al., 2005, Knodel et al., 2010, Chesney et al., 2000, Bangsberg et al., 
2000, Byakika-Tusiime et al., 2005). Generalising this literature to pre-ARV care is, however, 
exigent since the challenges, barriers or practical policy implications for uptake and loss to 
follow-up during pre-ARV may be different because the health situation, care demands and 
social-psychological contexts for PLHIV without AIDS and those with AIDS are different. There 
is also a lack of literature on feasible, community-oriented, low-cost interventions likely to 
improve uptake of pre-ARV care and subsequent timely initiation of ART in resource-poor 
settings.  
 
The purpose of this thesis is to explore reasons for failure to take up or loss to follow-up of 
PLHIV during pre-ARV care from the perspective of the PLHIV themselves, in order to evaluate 
low-cost interventions for enhancing regular pre-ARV care and subsequent timely initiation of 
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ART in Uganda. The thesis also seeks to understand and assess crucial risk factors for very late 
initiation of ART in Uganda for purposes of policy advocacy and planning. 
 
We therefore explore the views of PLHIV who did not take up or had been lost to follow-up 
during pre-ARV care and their caretakers on reasons for non-uptake or loss to follow-up during 
pre-ARV care, and evaluate the effect of low-cost interventions on uptake of pre-ARV care. We 
also seek the views of PLHIV who had initiated ART in time and those who initiated ART very 
late and their caretakers on reasons for very late initiation of ART, and assess crucial risk factors 
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Figure 2. Schematic framework for HIV/AIDS care and research questions analysed in this thesis 
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To investigate uptake and loss to follow-up of people living with HIV under pre-ARV care and 
delayed initiation of ART among PLHIV in Iganga district, Uganda, in order to inform policy and 




I. To explore reasons for loss to follow-up of PLHIV under pre-ARV care from the perspective of 
the staff and PLHIV in Iganga district, Uganda (sub-study I) 
 
II. To evaluate the effect of extended counselling on uptake of pre-ARV care in Iganga district, 
Uganda (sub-study II). 
 
III. To understand reasons for delayed ART initiation from the PLHIV/caretakers’ own 
perspectives in Iganga district, Uganda (sub-study III).  
 
IV. To assess risk factors for very late initiation of ART in Iganga district, Uganda (sub-study 
IV).  
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6.0 METHODS 
6.1 Study area and study population 
 
The studies in this thesis were conducted in Iganga district located in the east of the republic of 
Uganda. Uganda is a landlocked country located in East Africa covering an area of 241 550.7 
km
2
, of which 41743 km
2
 are open water and swamps, and 199 807 km
2
 is land. The projected 
total population by 2010 is 30.7 million people with a median age of 15 years (UBOS, 2009). 
Iganga district is one of the 112 administrative districts that constitute the country, with an 
approximate population of 600 000 people. The district is located 115 km east of the capital, 
Kampala (Figure 3). The area is predominantly rural with only about 7% living in an urban or 
peri-urban environment. The majority of the people belong to the Bantu ethnic tribe called 
Basoga, most of whom depend on subsistence farming of food crops. 
 
There are 101 health units in the district, 83 of which are owned by the Government and 18 by 
NGOs. District ART services are organised according to the Uganda national hierarchical referral 
system, where 70 of the units are health centres; 2 (HC II) offering only cotrimoxazole refills and 
home-based care services to PLHIV; 27 are HC III offering VCT, pre-ARV and home-based care 
services to PLHIV; and 3 HC IV and 1 general hospital offer routine counselling and testing, 
home-based care, pre-ARV care and ART services to PLHIV. Other care providers include over 
200 private drugstores/private clinics located in Iganga town and several other smaller towns 
scattered around the district. Most of the drugs commonly found in these drugstores and clinics 
include painkillers, assorted antibiotics and cheap antimalarials, but no ARVs. There are no other 
accredited ART providers in the district, although over 100 traditional and spiritual healers are 
presumed by the community to offer “similar” services (DHO, 2009). 
 
Prospective and current ARV users, health workers and managers as well as members of the 
community in the district were interviewed for this thesis.  
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Figure 3. Map of Uganda showing the study district (Iganga). 
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Over 30 000 people (5.3% of the district’s adult population) currently live with HIV in Iganga 
district and 4500 PLHIV are presumed to be eligible for ART according to the national threshold 
for ART initiation of CD4 <200 cells/µl (MOH, 2006, UNAIDS/WHO, 2007). Currently only 
1150 PLHIV (i.e. approximately 25% of those in need) are known to access ART in the district  
 
Approximately, 40% (360 out of 900) of PLHIV who initiated ART between 2004 and 2009 at 
Iganga hospital had a CD4 count of <50 cells/µl, with a median of 126 (range 14-198 cells/µl). 
Similarly, only 10% of the clients who tested HIV-positive for the first time between 2004 and 
2007 at the hospital took up and regularly attended pre-ARV services, while 90% have been lost 
to follow-up.  
 
Until 2008, when two more health centres were accredited to offer ART services, ART could only 
be accessed at Iganga General Hospital. The Iganga district ART services, occasionally managed 
by a medical doctor but more often by an assistant physician or a nurse and offering refills of 
ARVs and cotrimoxazole, adherence counselling, and psychosocial and nutritional support once a 
week, are quite representative of HIV care in rural Uganda (DHO, 2008). 
6.2 Study design 
 
We employed both qualitative and quantitative methods for the studies in this thesis. Qualitative 
methods were used to get an in-depth understanding of the awareness, experiences, views, beliefs, 
sociocultural and contextual factors that influenced PLHIV behaviour towards regular pre-ARV 
care and timely/late initiation of ART. We thus conducted key informant interviews (KIIs) with 
staff at the pre-ARV clinic, focus group discussions (FGDs) with caretakers of PLHIV and in-
depth interviews (IDIs) with PLHIV, half of whom had dropped out of pre-ARV care, for study I. 
We also conducted IDIs with PLHIV who initiated ART at 50 - 200 CD4 cells/µl and those who 
initiated very late, at CD4 < 50 cells/µl, and FGDs with caretakers of PLHIV on ART to get an 
in-depth understanding of reasons for delayed initiation of ART for study III.  
 
One quantitative design used was a randomised controlled trial whose participants were newly 
screened PLHIV to evaluate the effect of extended counselling on uptake of pre-ARV care, in 
study II. The other was an unmatched case-control study where PLHIV who started ART with a 
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CD4 cell count of <50 cells/µl (very late initiators) were classified as cases and PLHIV who 
initiated ART at CD4 between 50-200 cells/µl (late initiators) were the controls. The objective 
was to assess risk factors for very late initiation of ART in study IV.  
6.3 Data collection methods  
6.3.1 Qualitative methods 
 
Qualitative research is an inquiry process of understanding based on distinct methodological 
traditions of inquiry that explore a social or human problem. The researcher builds a complex, 
holistic picture, analyses words, reports detailed interviews with informants and conducts the 
study in a natural setting. It is therefore important that the researcher or research team understand 
the sociocontextual aspects of the subject under study (Dahlgren et al., 2004). The research team 
for the qualitative studies was multi-disciplinary, and included an indigenous public health 
physician who has managed PLHIV in the area for over 10 years and a social scientist with 
experience in conducting similar research in the study setting. Other members were research 
assistants who moderated and took notes for the study. They were from the district and spoke and 
understood the native language. The inquiry methods employed included FGDs, KIIs and IDIs. 
 
Focus group discussions (FGDs) 
An FGD enables the researcher to get an understanding from a group of people about their 
perceptions, opinions, beliefs, values, understanding and attitudes towards a product, service, 
concept or other ideas. Questions are asked in an interactive group setting where participants are 
free to talk with each other (Henderson and Naomi R, 2009, Kitzinger, 2005). Participants in 
FGDs are specifically selected to explore the range of beliefs in a study population. The group 
dynamics in an FGD facilitate the collection of relatively detailed information on prevalent 
attitudes, ideas, conflicts and contradictions. The interaction among the participants in FDGs is 
useful in exploring the individuals’ contextual views about the subject of study. FGDs therefore 
generate more information about a subject, because participants are able to build on each others’ 
response (Dahlgren et al., 2004, Khan and Manderson, 1992, Rice P L and Ezzy, 1999, Holloway, 
2008). Because they are subjective, FGDs allow the researcher to access different types of 
communication such as laughter, teasing, jokes, anecdotes or arguments, which may reveal more 
than what people ordinarily share (Stewart DW et al., 2007). The disadvantages of FGDs are that 
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sometimes minority opinions are suppressed, and if not carefully conducted the researcher is 
likely to drive the group interaction on his own perceptions about the topic of study. Also, 
because of group dynamics FGDs may not generate the individual complex beliefs and practices 
within the group (Rice P L and Ezzy, 1999, Hardon A et al., 2001).  
 
In study I we conducted FGDs with friends or relatives who lived with or cared for PLHIV to 
explore their attitudes and awareness about pre-ARV care. The FGD participants were 
volunteered by the respective PLHIV. Attitudes towards pre-ARV care among these informants 
influence the health care-seeking decisions made by PLHIV. In all six FGDs were conducted, 
three with men and three with women. Each FGD had 6 - 12 participants, constituting 59 
participants in total. The FGD guide explored knowledge on pre-ARV care and its importance, 
perceptions about pre-ARV services and knowledge about availability and packages of services 
and challenges/barriers to access to pre-ARV services.  
 
In study III FGDs were conducted with community members who lived with or looked after the 
ART clients to generate debate and explore views on reasons for late ART initiation. The FGD 
participants were volunteered by the respective ART clients. In total 10 FGDs were conducted, 
five with men and five with women, separately, to give participants a chance to express 
themselves more freely. Each group comprised 6 - 12 participants, reaching a total of 112 
members.  FGDs were not carried out with the PLHIV because many of them had not disclosed 
their status to outsiders, and they therefore did not want to discuss their personal treatment in 
groups.   
 
Key informant interviews (KIIs) 
KIIs are used in qualitative research to explore the subjective meanings and interpretations which 
individuals give to their experiences. KIIs are a way to obtain information from people who are in 
a position to know not only what individuals or the community do but why they do it. Key 
informants are normally chosen on the basis that they have special assets that make them 
knowledgeable about the topic of interest (Marshall and Rossman, 2006).  
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In study I five KIIs were held to understand the views of the health managers and providers on 
client or system barriers or facilitators for uptake and loss to follow-up of PLHIV under pre-ARV 
care. They were chosen on the basis of their experience in managing PLHIV. The KII participants 
were purposively selected from Government facilities since no non-governmental clinics offered 
comprehensive HIV care in the district during the period under study. All the KIIs with the 
managers or providers were conducted in English. 
 
Indepth interviews (IDIs) 
An IDI is a qualitative research method which proceeds as a confidential and secure conversation 
between an interviewer and a respondent. The method allows the researcher to get the inside 
views, opinions, beliefs or other social contextual issues related to the topic of study in the 
respondents’ own environment. The method can thus produce exhaustive and varied knowledge 
from the interviewee experiences, opinions, beliefs or motives, which group interviews would not 
elicit. It is a suitable method if the subject of research is very sensitive or controversial. IDIs give 
the respondent time in peace to develop and give reasons or perceived meanings without being 
influenced by the opinions of others (Megafon, 2000, WHO, 2004, Lisa A and Guion, 2000, 
Holloway, 2008, Gretchen R Webber et al., 2010).  
 
In study I we conducted 10 IDIs, five with the PLHIV who had dropped out and five with those 
who regularly attended pre-ARV care from 2004 to 2007. PLHIV were selected because they 
were considered most knowledgeable about their own situation with regard to pre-ARV care 
(Boyden and Ennew, 1997). By interviewing them in their own environment, we were able to get 
their in-depth understanding of issues related to uptake or loss to follow-up of PLHIV under pre-
ARV care. A topic guide covering individual and family background, social networks and how 
they influence individual decisions on health, knowledge of pre-ARV care and its perceived 
importance, post-VCT access to information, challenges to regular pre-ARV attendance and 
individual and community perceptions on pre-ARV care was used. The PLHIV who had been lost 
to follow up were purposively selected and traced by the staff who attended to them during VCT.  
 
In study III we conducted a total of 20 IDIs, 10 with clients who started ART with a CD4 cell 
count of 50 - 200 cells/µl  and 10 with clients who started ART very late (with a CD4 <50 cells/ 
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µl). These clients were chosen because they were presumed to be more “knowledge rich” on the 
study topic in their own situations than anybody else. The respondents were randomly selected by 
their dates of starting ART using the ART registers. The two groups were chosen in order to 
allow comparative analysis of the factors affecting timely and late ART initiation. A guide 
covering individual and family background, prior pre-ARV exposure, knowledge of ART and its 
importance, knowledge of AIDS-defining symptoms, conditions associated with timely or late 
initiation of ART and social networks and how these affected individual health-seeking behaviour 
was used for the interviews. Interviews stopped when it was judged that a point of saturation had 
been reached and no more new information could be retrieved. 
 
6.3.2 Quantitative methods 
 
Quantitative methods are research techniques used to gather information dealing with numbers 
and other aspects of research that are measurable. They are used to test a hypothesis or determine 
an association between explanatory (independent) and outcome (dependent) variables. Statistics, 
charts, tables and graphs are often used to present the results of these methods. In this study we 
used a randomised controlled trial (RCT) and case-control design, as explained below. 
 
Randomized controlled trial (RCT) 
An RCT is one of the most
 
powerful tools of research - a study in which people are allocated at 
random to
 
receive one of several interventions. The term "intervention" refers in a wider sense to 
any maneuver
 
offered to study participants that is likely to have an effect on their
 
health status or 
the outcome of interest. Examples of such maneuvers are prevention strategies,
 
screening 
programmes or community intervention trials. Someone who takes part in an RCT is called a 
participant or subject (Stolberg et al., 2004). Random allocation of participants is aimed at 
ensuring that all have the same chance of being assigned to each of the study
 
groups (Altman, 
1991). The allocation should therefore not be done by
 
the investigators, the clinicians, or the study 
participants (Jadad, 1998). If randomisation is properly done, the baseline characteristics of the 
participants are likely
 
to be similar across all groups (Jadad, 1998). Because of randomisation 
selection bias is minimised, hence balancing both known and unknown prognostic factors in the 
assignment of treatments. In summary, RCTs are quantitative, comparative, controlled 
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experiments in which investigators study two or more interventions in a series of individuals who 
receive them in random order (MedicineNET, 2010). 
 
In study II we conducted an RCT with an intervention based on key messages from study I 
(reasons why newly screened PLHIV were not taking up or were getting lost to follow-up under 
pre-ARV care). The key message from study I was that the newly screened PLHIV were not 
getting enough post-test counselling on why and when to come back for pre-ARV care by 
overloaded staff. An intervention consisting of post-test counselling by staff trained in basic 
counselling skills, combined with monthly home visits by community support agents for ongoing 
counselling to newly screened PLHIV, was thus conducted in Iganga district, Uganda between 
July 2009 and June 2010. Participants (N=400) from three public recruitment centres were 
randomised to receive either the intervention, or the standard care (the existing post-test 
counselling, the control arm). 
 
The design was a parallel group balanced (1:1) client randomised and single-blind superiority 
controlled trial. Eligible participants consisted of all newly screened HIV-infected adult clients 
(>18 years) at the three recruitment centres at the start of the study, who were of sound mental 
status and not on the prevention of mother-to-child transmission (PMTCT) programme or bound 
to leave the district during the period of follow-up.  
 
The design involved following up newly screened PLHIV after post-test counselling for uptake of 
pre-ARV care at any health centre (level II-V) within the district, whichever was nearest to their 
homes, as would be jointly agreed by the counselling staff at the recruitment centre and the 
participant. Thus, following a positive HIV test at the RCT clinic in the three recruitment centres, 
participants were randomised into one of two arms: the control arm and the intervention arm. The 
participants in the control arm received standard care, including assignment of an identification 
number, declaration of the results, provision of cotrimoxazole prophylaxis and advice to the client 
to go for pre-ARV care at the nearest health centre every three months.  
 
Participants in the intervention arm received another form of specialised counselling and follow-
up. The specialised counselling was conducted by six health workers who had been trained in 
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basic counselling skills for three days at a direct financial cost of US $20 per staff member. 
During the training it was emphasised that those who had been trained should not share their new 
skills with the staff selected for the control arm. The counselling offered in the intervention arm 
similarly involved allocation of an identification number, declaration of the results to the client 
and cotrimoxazole prophylaxis. In addition, the counsellor encouraged self-disclosure of HIV 
status to the participant’s immediate family, promoted positive living with HIV and HIV 
prevention and emphasised the importance of going for pre-ARV care at the nearest health centre 
every three months. As part of the intervention these participants were also attached to an 
HIV/AIDS community support agent close to their area of residence, who visited them monthly at 
their homes for a two-hour counselling session and reminded them to go to the nearest health 
centre for quarterly pre-ARV care.  
 
HIV/AIDS community support agents are influential volunteers in the community or ART expert 
clients who have been sensitised and assigned the role of counselling and encouraging PLHIV to 
seek care and subsequently linking them to the service providers. The community support agents 
had been trained and registered by the district in the previous years but also received a one-day 
orientation about the study.  
 
The outcome measure was the proportion of newly detected and counselled PLHIV in either arm 
who had been to their nearest health centre for clinical check-up in the subsequent three months 
after enrolment. An allowance of an extra two months to return for check-up was considered for 
every participant to cater for any inevitable circumstances that might prohibit the participant from 
going for check-up. The participants in both arms were followed up and considered to have taken 
up (accepted) or not taken up (not accepted) pre-ARV care according to the following definition: 
those who went for clinical check-up at the nearest health centre at least once in the subsequent 
three months (+ two months, see above) were considered to have taken up pre-ARV care, while 
those who missed their scheduled appointment at the pre-ARV clinic in the subsequent three 
months (+ two months) were considered not to have taken up pre-ARV care (Figure 4). 
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Figure 4. Description of the trial time line for assessing uptake of pre-ARV care in Iganga district.  
 
 
Baseline data for every enrolled participant were collected through face-to-face interviews 
following a short structured questionnaire administered by a trained research assistant at each of 
the three recruitment centres. The baseline information included socio-demographic 
characteristics such as age, sex, education, religion, marital status, marriage status, occupation and 
number of people in the household. Information was also collected on knowledge of HIV 
transmission, prevention, pre-ARV care and its importance and stigma. For participants who went 
to their nearest health centre for pre-ARV care after three months (+ two months), information on 
reasons for going for care, disclosure and motivational factors for disclosure, any side-effects of 
cotrimoxazole, constraints to pre-ARV care seeking, condom use and number of sexual partners 
was also collected. The follow-up data were collected by a research assistant who had been 
identified at each of the participants’ agreed nearest health centres.  
 
 All the counsellors and corresponding research assistants were trained for three days on the study 
aim, design and tools. The study tools were pre-tested using a pilot study at another health centre 
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separately for each arm. Necessary changes were then made to the tools and the research 
assistants were given additional guidance. Throughout the study period random validity checks 
were conducted at the health centres by the first and second authors (LM and TN) to ensure 
compliance, and also to collect the completed corresponding questionnaires. The completed 
questionnaires were then checked for consistency, range of values and completeness. 
 
The sample size for the RCT was calculated using a formula suggested by Bland 2000, (Altiman 
and Brand, 1995). At a power of 80%, with estimated pre-ARV uptake of 50% for the control 
arm, and a target to detect a difference of absolute 14% in the intervention arm as significant at 
5% level, a minimum of 193 participants (rounded up to 200) per arm was found adequate. The 
number of newly screened PLHIV normally differs between the different study centres; it is twice 
as high at Iganga Hospital compared to Busesa and Kiyunga. Based on these proportions, 50% 
(200 participants, 100 in each arm) were enrolled at Iganga Hospital and 25% (100 
participants, 50 in each arm) were recruited at each of the other two recruitment centres (DHO, 
2009). 
 
In all the study centres participants were randomly assigned to receive the standard post-test 
counselling or extended counselling. Treatment assignment was randomly generated in blocks of 
four, based on computer-generated random number sequences provided by one of the statisticians 
in the study team (DK), who had no contact with the study participants. Assignment sequences 
were placed in opaque sealed envelopes and appropriate numbers sent to each of the study 
centres.  
 
At each centre participant enrolment was done by an assigned laboratory technician who carried 
out the HIV testing. After a client had tested HIV-positive, the technician at each centre asked the 
eligible client to pick and open an envelope from a batch of four for assignment to the appropriate 
arm. At each centre this procedure continued until the required allocated numbers per arm had 
been realised. Given the nature of the intervention, it was hard to mask the staff in the different 
arms as to which arm they themselves belonged to. However, none of the study subjects was 
informed of the details of the arm to which they had been assigned.  
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To limit contamination between and among the research assistants and the participants, each arm 
at every centre was put in different rooms at least 50 m apart. The staff members were also 
instructed not to share the nature and content of counselling they offered to the participants.  
 
Case control studies 
A case-control study is an analytical epidemiological study which compares individuals who have 
a specific disease or condition (cases) with a group of individuals without the disease or condition 
(controls). The proportion of each group having a history of a particular exposure or characteristic 
of interest is then compared. An association between the hypothesised exposure and the disease 
being studied will be reflected in a greater proportion of the cases being exposed.  It is 
advantageous for the controls to come from the same population as the cases, to reduce the chance 
that some other difference between the groups accounts for the difference in the exposure that is 
under investigation (EHIB, 2008).  
 
Case-control studies start with the outcome and look backward for the exposure. Case-control 
studies can be used to study infrequent (rare) diseases, and are relatively inexpensive because no 
follow-up is necessary. Because exposure is ascertained retrospectively, the investigator does not 
have to wait for the accumulation of enough individuals who are developing the disease. Some of 
the disadvantages of using a case-control design are that they cannot be used to compute 
incidence rates and they are prone to selection and recall bias (Kaelin, 2004). 
 
In study IV we conducted an unmatched case-control study of clients initiated on ART at Iganga 
Hospital to assess crucial risk factors for very late ART initiation. All cases and controls were 
selected from Iganga Hospital because it was the unit with the best updated ART register - and 
also the only ART-providing unit until 2008.  
 
The case definition was HIV-infected clients who started ART with a CD4 cell count of <50 
cells/µl (very late initiators). The control subjects consisted of clients who started ART with a 
CD4 cell count of 50-200 cells/µl (late initiators). The cut-off margins were based on the Iganga 
hospital clinic observation where patients who start ART with a CD4 count below 50 cells/µl are 
prone to death, while those who initiate ART at a CD4 count below 200 cells/µl are prone to 
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immune reconstitution syndrome and always take a lot of time to resume normal functional 
ability. The margins were also based on studies in nearby settings where initiating ART at a CD4 
below 50 cells/µl was associated with a higher risk of mortality (HR 1.006, 95% CI 1.003 to 
1.008) (Smart, 2007) and the  current WHO recommendation for starting ART at a CD4 cell 
count of < 350 cells/µl (WHO, 2009a). The cut-off points aimed at enabling us to classify other 
low counts, such as a CD4 count of 60 cells/µl, for example, which although <250 cells/µl (the 
recommended national threshold) is certainly not timely ART initiation. 
 
All adult clients on ART in the hospital who enrolled for ART during the study period (January 
2005 - December 2009) were eligible for the study. Given that the mean and median CD4 cell 
counts at initiation of ART for all clients were 122 and 126 cells/µl respectively (range 14-198 
cells/µl) (DHO, 2009), these margins made all clients initiated on ART during the study period 
eligible. Clients on ART that were alive and of sound mental status were included in the study. 
Clients who initiated ART at the hospital before 2005 were excluded to reduce the risk of bias due 
to the unmet demand that had to be catered for during the first months of programme initiation in 
2004. Clients in the PMTCT programme were also excluded because they had already been 
enrolled in another study at the same site (DHO, 2009).  
 
 The Fleiss formula (Fleiss, 1981) for sample size calculation was used under the following two 
assumptions: a) that the true ratio of cases to controls as observed from the hospital ART register 
was 40:60; and b) that exposure to pre-ARV care was similar for both cases and control subjects 
(50%). Exposure to pre-ARV care was used in sample size calculation because it is a very 
important explanatory variable for timely entry into HIV care (Lawn et al., 2010, Sanjobo et al., 
2008). Thus at a power of 80%, with a target to detect a difference of absolute 16% as significant 
at 5% level, a minimum of 124 cases and 186 controls were needed for the study. To cater for 
clients who would withdraw consent or be difficult to trace for interviews, an additional 20% 
margin of subjects were recruited. In total 152 cases and 243 controls were recruited for the study.  
  
The cases and control subjects were identified using systematic random sampling as described 
below. A chart review of the ART register at the hospital for the study period was done. From the 
review, all clients who satisfied the selection criteria above were identified and divided into cases 
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and control subjects in accordance with the CD4 count definitions given earlier. For each category 
(case vs control), a list with all clients’ ART registration numbers was divided into serial pairs. 
Using simple random sampling, one of the two first numbers of each starting serial pair for each 
category was selected as the first client for the study, followed by every subsequent third client in 
each category until the desired sample size had been realised. 
 
Trained research assistants then traced the clients for interviews using medical record information 
on address/place of living to seek informed consent. All the selected cases were subsequently 
interviewed, but 31 controls could not be interviewed either because they withdrew their consent 
for the interviews or could not be traced. Further scrutiny of records for the 23 who could not be 
traced showed that they were all males, and the 8 who withdrew consent were all women.Thus, 
the total number of interviewees enrolled in the study was 152 cases and 202 control subjects. 
 
Semi-structured interviewer-administered questionnaires were employed for the study. Six 
research assistants who had previous experience in quantitative data collection from PLHIV 
within the Iganga-Mayuge demographic and health surveillance site interviewed the clients. The 
research assistants were trained for four days on the study aim, design and tools. The tools were 
pilot-tested at the nearest health centre IV offering ART. Experiences from the pilot study were 
discussed at an extra session together with the research assistants. Necessary changes were made 
to the tools and the assistants received additional guidance.  
 
The data collected included individual/community-related factors associated with late/very late 
initiation of ART, such as the clients’ age, gender, education, occupation, religion, number of 
people living in the household, marriage status and marital status. Other individual/community-
related information included client-perceived barriers to timely ART, client perceptions and 
misconceptions about ARVs, CD4 count at ART initiation, and presence of family support. 
Health system-related data such as client-reported access to information on when to start ARVs 
after VCT, access to post-test pre-ARV care and waiting time for CD4 cell count results was also 
collected. Other health system-related data collected included waiting time between prescription 
and accessing ARVs (and if >1 month the reasons for waiting that long), clients’ distance from 
the ARV centre, any care sought from other providers such as traditional/spiritual healers before 
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coming to the ARV centre, and reasons for their choice of service provider. The data were 
checked for consistency and completeness by the first and second authors (LM and TN) 
throughout the data collection period. 
6.4 Data management 
 
 For studies I and III (qualitative studies) the entire data collection process was supervised and 
assessed by the first author of this thesis (ML), who is an indigenous public health physician, and 
the second author (XN), who is a social scientist with experience in qualitative research. Two 
indigenous research assistants chosen on the basis of their training and experience in carrying out 
social research moderated and took notes for the studies. The research assistants were trained for 
two days to become acquainted with the study aim, design and tools.  
 
Role-plays were used to prepare the assistants for the different situations that were likely to arise 
in their interaction with the informants. Experiences from the role-plays were discussed at an 
extra session and further methodological guidance was given. All KIIs with health managers and 
providers were conducted in English, while the FGDs and the IDIs with PLHIV or their 
caretakers were conducted in Lusoga (the local language) and tape recorded to enable us to obtain 
the details and ensure an accuracy that we would not get from memory or field notes (Ryan et al., 
1996). The tapes were later transcribed and translated into English verbatim (for the FGDs and 
IDIs) by the interviewers. The authors listened to the tapes to confirm the credibility of the 
information. Data collection stopped when information relating to the topic guides revealed no 
new information. Data analysis was iterative, including reviews and discussions at different stages 
of data collection, and appropriate modifications were made in the tools to address emerging 
issues.   
 
In studies II and IV all the completed questionnaires were checked for consistency and 
completeness by the first and second authors (LM and TN) during the study period. The checked 
questionnaires were then double-entered into the computer using Epi-Info version 2000 (Centers 
for Disease Control, Atlanta), and the two data sets were checked for discrepancies and further 
cleaned using analysis commands, lists and frequencies, and any range and consistence errors 
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identified were corrected. The data were then exported to STATA8 (STATA Corporation, 
College Station, Texas, USA) for univariate, bivariate and multivariate analysis.  
 
6.5 Data analysis 
 
Studies I and III (qualitative) were analysed using content analysis. The units of analysis were the 
interviews and FGDs. Content analysis can be manifest or latent; however, there is no clear line 
dividing the two since both deal with interpretation of findings, the only difference being a 
variation in the level of abstraction. While manifest content analysis refers to the analysis of 
visible obvious components (Kondracki et al., 2002), latent analysis refers to the interpretation of 
the underlying meaning of the text (Downe-Wamboldt, 1992). Indeed, some authors prefer to 
describe the analysis as being close or not close to the text (Graneheim and Lundman, 2004). The 
content analysis used for these studies involved reading and reviewing texts of the entire 
interview back and forth to identify meaningful units in relation to the study aims (Morse and 
Field., 1995). The meaningful units were condensed into codes, categories and themes. During 
this process the researchers shared and debated the way each of them understood or coded the 
data until consensus was reached on the appropriate codes and themes. 
 
In study II (RCT) data analysis was carried out in three stages. Stage 1 involved a description of 
baseline characteristics of the participants in the two arms to find out how comparable they were 
with respect to potential confounders such as age, education, and marital status. Chi-square and 
the t-test were used to test for any significant differences between the two arms for categorical 
and continuous data respectively.   
 
Stage 2 involved bivariate analysis to establish the relationship between the different independent 
variables and the outcome variable. The risk ratios (RR) comparing uptake of pre-ARV care in 
intervention arm to the control arm, were computed as well as their 95% confidence intervals 
(CI). All variables where the association with the outcome variable had a p-value less than 0.2 
were considered important for inclusion in the next stage of analysis. A stratified analysis in 
which the computed RRs for different levels of each independent variable were pooled using the 
Mantel-Haenszel RR was also performed. The Mantel-Haenszel RR was performed to adjust for 
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differences in risk ratios of uptake of pre-ARV at different levels of each independent variable. A 
Mantel-Haenszel procedure is robust and offers an elementary alternative of computing a 
common rate ratio to the earlier used maximum likelihood estimates. 
 
Stage 3 was a multivariate analysis where different models assessing the independent effect of the 
intervention on uptake (primary outcome) of pre-ARV care were examined by controlling for 
different potential confounders. The multivariate analysis started by computing the RR generated 
by the intervention alone on uptake of pre-ARV care. Other models were then computed by 
cumulatively adding each of the independent variables that had been significant in stage two 
above until all the variables had been exhausted. The intervention was considered significant if 
the RR generated by the intervention alone did not change significantly for the different generated 
models.  
  
In study IV (case-control study) we conducted univariate, bivariate and multivariate analysis 
using Stata. Following frequency distributions and cross-tabulations, the strength of association 
between variables was determined using odds ratios (OR) and 95% CI. For the bivariate analysis, 
cross-tabulations were run for each independent variable against the outcome variable (very late 
ART initiation). An independent variable was presumed to be significant if the cross-tabulation 
generated a p-value of <0.2. Multivariate analysis was also done to control for confounding and 
test effect modification. A logistical model was constructed to determine the best model for 
prediction of very late initiation of ART among ART clients. This process involved putting all 
plausible variables found to be significantly associated with very late initiation of ART among 
ART clients during the bivariate analysis into an initial model. The best model was thereafter 
generated using backward elimination and likelihood ratios to select the statistically significant 
variables.  
6.6 Ethical considerations 
 
The studies were approved by the Makerere University School of Public Health Higher Degrees  
Research and Ethical Committee and the Uganda National Council for Science and Technology. 
Study II (RCT) was registered by Current Controlled Trials Ltd C/O BioMed Central Ltd as 
ISRCTN94133652 at http://www.controlled-trials.com. The district authorities approved the 
  41  
studies. The informants were told about the aims of the studies, their discretion to participate or 
withdraw at any time, and were assured that all information obtained from them would be kept 
confidential. The anticipated benefits of the studies such as an overall improvement in 
comprehensive HIV care for the individuals and the community were clearly explained to the 
participants. Anticipated harm caused by the studies, such as sharing the participants’ HIV status 
with the research assistants at the follow-up health centre and/or the community support agents 
were also clearly explained to them. All the participants signed consent forms before any 
interviews could be commenced. To ensure confidentiality and minimise stigma the PLHIV were 
approached by the staff who attended to them during VCT. 
 
6.7 Summary of methods  
 
The methods used in the four studies and the timeframes are summarised in Table 5. 
 
Table 5. Summary of methods and timeframe for the studies 
 
Study Setting Design Data collection method & 
study population 
Data analysis Year 







5 KIIs, 6 FGDs and 10 IDIs Content analysis  2008 
      
II Facility- and 
community-based 























and multivariate  
Logistical regression  
2010 
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7.0 RESULTS 
 
7.1 Reasons for loss to follow-up of PLHIV under pre-ARV care (study I) 
 
Reasons for dropping out of pre-ARV care that emerged from this study included inadequate 
counselling, competition from traditional/spiritual healers, transportation costs, waiting time, lack 
of incentives and gender inequality.  
 
7.1.1 Inadequate counselling 
Most informants indicated that the post-test counselling given to the newly screened PLHIV was 
inadequate. The overloaded staff acknowledged that they did not offer sufficient post-test 
counselling to the PLHIV about the importance of regular pre-ARV attendance. Some PLHIV 
even thought it was necessary to go to the clinic only when they fell sick: 
 
“Really often the patients are many and we are few ... we don’t normally give them a lot of time 
for counselling, so sometimes maybe they don’t understand and we have not followed them so 
we lose them” (Male health worker) 
 
“I only know I should go to the hospital when I have a problem. They did not tell us, are we 
supposed to go back? Anyway, they did not tell us” (Female (39), drop-out from pre-ARV care) 
 
In contrast, the PLHIV who did not drop-out of pre-ARV care acknowledged the significance of 
adequate counselling: 
 
“I was encouraged to go back because of the counselling I received and the treatment that I 
always get from the clinic” (Female (38), adherent to pre-ARV care). 
 
7.1.2 Competition from traditional/spiritual healers 
Traditional/spiritual healers provided other forms of services in direct competition to the pre-
ARV services from formal health providers. Some spiritual healers campaigned against some pre-
ARV services, like cotrimoxazole prophylaxis, and portrayed the formal pre-ARV service as 
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useless since it could not cure HIV. The PLHIV perceived the healers as being affordable and 
easily accessible: 
“Some of the churches have even discouraged some of our patients from taking drugs. They tell 
them that when you take drugs you are showing God that you lack faith, yet the healing in church 
comes with faith.” (Male, health worker)  
 
“Sometimes we go to traditional or spiritual people. Many of us we meet there. You know those 
people, you don’t need a lot of transport to reach them. They also handle us well, give us advice 
and sometimes food or you can even sleep there if you are from far. I prefer them.” (Female (33), 
drop-out from pre-ARV care)   
 
7.1.3 Transportation costs and waiting time 
Lack of transport was often mentioned as a barrier to regular pre-ARV attendance. Some PLHIV 
had difficulties affording transport costs to go to the units for the services unless they received 
collateral support. Others preferred to use the little money they had to purchase the cotrimoxazole 
locally rather than spending several times the cost on transport to get to the health units for the 
service. Another reason mentioned by the PLHIV for dropping out of pre-ARV care was the long 
waiting time at the clinics:  
 
“The problem I am seeing is transport ... at our church we organise for transport then take the 
members for testing and attending the clinic frequently.” (Female informant, FGD) 
 
“I just buy cotrimoxazole and take. If you compare going to the clinic, staying in the long queue, 
you feel thirsty so it’s better to use 500 and you buy cotrimoxazole instead of using 1500 Uganda 
shillings for transport.” (Female (39), drop-out from pre-ARV care) 
 
7.1.4 Lack of incentives 
It was expressed that neither the health workers nor the respondents had fully grasped the benefits 
of offering or attending pre-ARV care. Some health workers did not want to prioritise PLHIV 
without obvious symptoms, given the high workload and few resources they had: 
 
“But really you know sometimes with the few resources we even ask ourselves do these people 
need us. They are doing work normally, so we prefer to give more attention to those on ART.” 
(Female health worker) 
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On the clients’ side, some PLHIV who had dropped out of the pre-ARV programme also 
expressed a lack of incentive to regularly attend pre-ARV care, since they felt healthy and able to 
work normally. They preferred to use their time and resources for other pressing needs: 
 
“Me, I am still healthy and doing my work. Why should I waste money on transport to get nothing? 
I rather spend it on food and fees for my children.” (Female (39), drop out from pre-ARV care) 
 
Others expressed the need for incentives such as bedding for PLHIV as a motivation for not 
dropping out of pre-ARV care, as in the following quote:  
 
“You should give incentives to the clients like us who have children, you should provide beddings. 
People get fed up when you go for meetings at the clinic and come home with nothing.” (Female 
(22), drop-out from pre-ARV care) 
 
7.1.5 Gender inequality 
Some female informants expressed the fear of being beaten or divorced by their husbands as a 
reason why many women did not attend the pre-ARV clinic, even when they had tested and knew 
they were HIV-positive: 
 
“Also us we have a problem. If you go and test alone and find out that you are HIV-positive, we 
fear telling our husbands because if you tell him he will say that you brought the disease, so he will 
either beat you or send you away from your home.” (Female informant, FGD) 
 
Other females were denied access to pre-ARV care by their husbands out of ignorance. One man 
with four wives denied them access to pre-ARV care but kept telling them to take cotrimoxazole 
in the guise of preventing malaria: 
 
“Of course he had knowledge before but he could not tell us. I was so bitter about it because if I 
had known it early enough even the herpes zoster would not have come. He used to tell us to take 
cotrimoxazole every day, two of them. … He used to tell us that they treat malaria and one can 
never get sick.” (Female (30), drop-out from pre-ARV care) 
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7.2 Effect of extended counselling on uptake of pre-ARV care (study II) 
 
The study participant flow included a total of 400 newly screened PLHIV who were deemed 
eligible and enrolled for the study. In the intervention arm, 135/200 clients took up and returned 
for pre-ARV care and 65/200 did not return for pre-ARV care. In the control arm, 77/200 clients 



























Figure 5. Participant flow diagram from enrolment to analysis. 
 
 
The majority of the participants in both arms were comparable with regard to gender (p=0.75), 
age (p=0.48), education status (p=0.83), marriage status (p=0.90), occupation (p=0.62), distance 
to the centre (p=0.56) and number of people living in the household (p=0.23). There were, 
however, observed differences between the two arms with regard to pre-ARV awareness 
(p=0.008), religion (p=0.02) and marital status (p=0.02), although on further statistical analysis 
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these differences did not significantly influence the effect of the intervention on the outcome 
(Tables 6 and 7). 
Table 6. Background characteristics in the two study arms in Iganga district (N=400). 
Characteristics Control (n=200)             Intervention (n=200)  
 
Chi-square /t test 
  No. (%) No. (%) 
(p value) 
Centre   
 
Centre 1 (Busesa) 50 (25.0) 50 (25.0) 
 
Centre 2 (Iganga) 100 (50.0) 100 (50.0) 
 
Centre 3 (Kiyunga) 50 (25.0) 50 (25.0) 
0.000 (1.00) 
Sex   
 
Male 73 (36.5) 70 (35.0) 
 
Female 127 (63.5) 130 (65.0) 
0.098 (0.75) 
 Age (years)   
 
18-24 39 (19.5) 29 (14.5) 
 
 25-34 57 (28.5) 68 (34.0) 
 
 35-44 58 (29.0) 56 (28.0) 
 
 45-70 46 (23.0) 47 (23.5) 
2.480 (0.48) 
Education   
 
 Low educated (none/primary) 130 (65.0) 128 (64.0) 
 
 Well educated (secondary +) 70 (35.0) 72 (36.0) 
0.044 (0.83) 
Marital status   
 
 Unmarried 82 (41.0) 61 (30.5) 
 
 Married 118 (59.0) 139 (69.5) 
4.799 (0.02) 
Marriage status (for married people only)    
 
Monogamous 62 (52.1) 72 (51.8) 
 
Polygamous 56 (47.9) 67 (48.2) 
0.014 (0.90) 
Occupation   
 
 Farmer 134 (67.0) 140 (70.0) 
 
 Trader/business 48 (24.0) 40 (20.0) 
 
 Salary/wage earner 18 (9.0) 20 (10.0) 
0.964 (0.62) 
Distance to unit (mean) 21.0 (SD=19.6) 22.0 (SD=21.1) 
0.590 (0.56) 
Household size (mean, SD) 6.1 (SD=3.8) 6.7 (SD=5.6) 
1.200 (0.23) 
Religion   
 
 Christian 117 (58.5) 140 (70.0) 
 
 Muslim 83 (41.5) 60 (30.0) 
5.757 (0.02) 
Pre-ARV awareness   
 
 Aware 56 (28.0) 81 (40.5) 
 
 Not aware 144 (72.0) 119 (59.5) 
6.940 (0.01) 
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Both the bivariate and multivariate analyses were conducted using intention to treat, with a 
sample size of 200 participants for the intervention arm and 200 for the control arm. In the 
bivariate analysis, participants in the intervention arm were more likely to return for pre-ARV 
care compared to those in the control arm, with overall percentages of 38.5% and 67.5% for the 
control and intervention arms respectively and an unadjusted RR of 1.8 (95% CI: 1.4-2.1) (Table 
7). Thus participants in the intervention arm were 80% more likely to take up pre-ARV care 
compared to those in the control arm.  
 
The effect of the intervention remained significant after adjusting for the combined effect of each 
of the independent variables in stratified analysis, with a Mantel-Haenszel RR of pre-ARV uptake 
in the intervention arm compared to the control arm ranging from 1.6 to 1.8. Specifically, the 
Mantel-Haenszel RRs and their 95% CIs stratified for independent variables were as follows: 
recruitment health centre (Busesa) 1.8 (95% CI 1.4-2.1), sex (male) 1.7 (95% CI 1.4-2.1), age 
group (18-24 years) 1.8 (95% CI 1.4-2.2), education (low education) 1.8 (95% CI 1.4-2.2), 
marital status (unmarried) 1.8 (95% CI 1.4-2.1), marriage status (monogamous) 1.8 (95% CI 1.4-
2.3), occupation (subsistence farmer) 1.8 (95% CI 1.4-2.1), distance to health facility (1-10 km) 
1.8 (95% CI 1.4-2.0), number of people living in household with PLHIV (1-4) 1.8 (95% CI 1.4-
2.2), religion (Christian) 1.7 (95% CI 1.4-2.1) and pre-ARV awareness (aware) 1.6 (95% CI 1.3-
2.0). A test of homogeneity of the combined Mantel-Haenszel RR showed no significant 
difference among the strata. The result reaffirms the significant effect of extended counselling on 
uptake of pre-ARV care (Table 7). 
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Table 7. Uptake of pre-ARV care in both arms stratified for different categories of baseline characteristics in 







p-value, crude RR 
 (95% CI) 
Mantel-Haenszel  
RR 
Recruitment centre    
 
Centre 1 (Busesa) 36.0 68.0   0.003   1.9 (1.3-2.9) 
1.8 (1.4-2.1) 
Centre 2 (Iganga) 39.0 68.0 <0.001   1.7 (1.3-2.3) 
 
Centre3 (Kiyunga) 40.0 66.0   0.013   1.7 (1.1-2.5) 
 
Sex     
Male 30.1 64.3 <0.001   2.1 (1.4-3.2) 1.7 (1.4-2.1) 
Female 43.3 69.2 <0.001   1.6 (1.3-2.0)  
Age (years)     
18-24 41.0 65.5   0.050   1.5 (1.1-2.5)  1.8 (1.4-2.2) 
25-34 35.1 64.7   0.002   1.8 (1.2-2.7)  
35-44 44.8 71.4   0.006   1.6 (1.2-2.2)  
45-70 32.6 68.1   0.002   2.0 (1.3-3.3)  
Education     
Low educated 
none/primary 40.0 69.5 <0.001  1.7 (1.4-2.2) 
1.8 (1.4-2.2) 
High educated (secondary 
+) 35.7 63.8   0.001  1.8 (1.3-2.6) 
 
Marital status     
Unmarried 39.0 68.5 <0.001  1.8 (1.3-2.4) 1.8 (1.4-2.1) 
Married 38.1 66.9 <0.001  1.8 (1.4-2.3)  
Marriage status     
Monogamous 35.5 65.3   0.001  1.8 (1.3-2.7) 
1.8 (1.4-2.3) 
Polygamous 39.0 68.9 <0.001 1.8 (1.3-2.4)  
Occupation     
Farmer 40.3 65.0 <0.001  1.6 (1.3-2.1) 1.8 (1.4-2.1) 
Trader 39.6 72.5   0.003  1.8 (1.2-2.7)  
Salary earner 22.2 75.0   0.008  3.4 (1.4-8.3)  
Distance to facility (km)     
1-20 43.3 72.8 <0.001  1.7 (1.3-2.1) 1.8 (1.4-2.0) 
21-40 29.0 60.0   0.010  2.0 (1.2-3.6)  
41-90 33.3 61.0   0.016  1.8 (1.1-3.0)  
People in household      
1-4 41.2 66.2   0.005  1.6 (1.2-2.2) 1.8 (1.4-2.2) 
5-9 36.4 76.3 <0.001  1.9 (1.4-2.5)  
10-45 40.9 71.4   0.049  1.7 (1.0-3.0)  
Religion     
Christian 43.6 75.0 <0.001  1.7 (1.4-2.2) 1.7 (1.4-2.1) 
Muslim 31.3 50.0   0.024  1.6 (1.1-2.4)  
Pre-ARV awareness     
 Aware 60.7 86.4   0.002  1.4 (1.1-1.8) 1.6 (1.3-2.0) 
 Not aware 29.9 54.6 <0.001  1.8 (1.1-1.8)  
Overall analysis 38.5 67.5   0.001  1.8 (1.4-2.1)  
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In the multivariate analysis to control for potential confounders, all models generated did not 
change the adjusted RR obtained by the bivariate analysis between the intervention and the 
outcome RR of 1.8 (1.4-2.1) (Table 8). 
 
Further analysis also showed that all participants in both arms were well informed about HIV 
transmission, prevention and AIDS-defining symptoms. The results also show that counselling 
was a major reason for participants coming back for care in the intervention arm (91.6%), 
compared to (8.4%) in the control arm (Figure 6). In addition, the majority of clients in the 
intervention arm (64.5%) who came back for pre-ARV care had disclosed their HIV status to their 






Figure 6. Study II (RCT) participants’ reasons for coming back for care in both arms in Iganga district. 
 
  50  
 
Table 8. Multivariate analysis to assess the effect of the intervention on uptake of pre-ARV care in Iganga 
district.  
 
Model /variable (reference) RR (95% CI) p value 
Model 1   
           Intervention* 1.8 (1.4-2.1) <0.001 
Model 2   
           Intervention* 1.7 (1.4-2.1) <0.001 
           Sex (female/male) 1.1 (1.0-1.4)  
Model 3   
           Intervention* 1.7 (1.4-2.1) <0.001 
           Sex (female) 1.2 (1.0-1.4)  
           Education(secondary/ primary) 0.9 (0.8-1.1)  
Model 4   
           Intervention* 1.7 (1.4-2.1) <0.001 
           Sex (female/male) 1.1 (0.9-1.4)  
           Education ( secondary/primary) 0.9 (0.8-1.1)  
           Age group ( base = 18-25 years)   
                25-34 1.0 (0.7-1.2)  
                35-44 1.1 (0.8-1.4)  
                45-70 1.0 (0.6-1.3)  
Model 5   
           Intervention* 1.7 (1.4-2.1) <0.001 
           Sex (female/male) 1.2 (0.9-1.4)  
           Education (secondary/primary) 0.9 (0.8-1.1)  
           Age group (base = 18-25 years)   
                25-34 0.9 (0.7-1.2)  
                35-44 1.1 (0.8-1.4)  
                45-70 1.0 (0.8-1.3)  
           Centre 2 (Iganga Hospital/Busesa) 1.0 (0.8-1.2)  
           Centre 3 (Kiyunga health subdistrict/Busesa) 1.0 (0.8-1.2)  
Model 6   
           Intervention* 1.8 (1.4-2.1) <0.001 
           Sex (female/male) 1.1 (0.9-1.4)  
           Education (secondary/primary) 0.9 (0.8-1.1)  
           Age group (base = 18-25 years)   
                25-34 0.9 (0.7-1.2)  
                35-44 1.1 (0.8-1.4)  
                45-70 1.0 (0.7-1.3)  
           Marital status (married/unmarried) 1.0 (0.8-1.2)  
Model 7   
          Intervention* 1.8 (1.4-2.1) <0.001 
           Sex (female/male) 1.2 (0.9-1.4)  
           Education (secondary/primary ) 0.9 (0.8-1.1)  
           Marital status (married/unmarried) 1.0 (0.8-1.2)  
           Occupation (trader/subsistence farmer) 1.1 (0.9-1.3)  
           Occupation (salaried/subsistence farmer) 1.1 (0.8-1.2)  
Model 8   
          Intervention* 1.8 (1.4-2.1) <0.001 
           Sex (female/male) 1.2 (1.0-1.4)  
           Education (secondary/primary) 0.9 (0.8-1.1)  
           Marital status (married/unmarried) 1.00 (0.8-1.2)  
           Occupation (trader/subsistence farmer) 1.1 (0.9-1.3)  
           Occupation (salaried/subsistence farmer) 1.1 (0.8-1.4)  
           Centre 2 (Iganga Hospital/Busesa) 0.9 (0.8-1.2)  
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           Centre 3 (Kiyunga health subdistrict/Busesa) 0.9 (0.7-1.2)  
Model 9   
          Intervention* 1.8 (1.4-2.1) <0.001 
           Sex (female/male)               1.1 (0.9-1.3)  
           Education (secondary/primary)               0.9 (0.8-1.1)  
           Marital status (married/unmarried)               1.0 (0.8-1.2)  
           Occupation (trader/subsistence farmer)               1.0 (0.8-1.3)  
           Occupation (salaried/subsistence farmer)               1.1 (0.8-1.4)  
           Distance to facility in km (base = 1-20 km)   
           21-40 km               0.8 (0.6-1.0)  
           41-90 km               0.9 (0.8-1.1)  
Model 10   
          Intervention*               1.7 (1.4-2.1) <0.001 
           Sex (female/male)               1.2 (1.0-1.4)  
           Education (secondary/primary)               0.9 (0.8-1.1)  
           Marital status (married/unmarried)               1.0 (0.8-1.2)  
           Occupation (trader/subsistence farmer)               1.0 (0.9-1.3)  
           Occupation (salaried/subsistence farmer)               1.0 (0.8-1.3)  
           People in house hold (base = 1-4)   
           5-9               1.0 (0.8-1.2)   
           10-45               1.1 (0.9-1.4)  
Model 11   
           Intervention* 1.7 (1.4-2.0) <0.001 
           Sex (female) 1.2 (1.2- 1.2)  
           Education (secondary/primary ) 1.2 (1.2-1.2)  
           Occupation (trader/subsistence farmer) 1.1 (1.1-1.1)  
           Occupation (salaried/subsistence farmer) 1.0 (1.0-1.0)  
           Centre 2 (Iganga Hospital/Busesa) 0.8 (0.8-0.8)  
           Centre 3 (Kiyunga health subdistrict/Busesa) 0.9 (0.9-0.9)  
           Religion (Christian/muslim) 0.8 (0.6-0.9)  
           Pre-ARV awareness (aware/not aware) 0.6 (0.5-0.7)  
*Statistically significant at 5% level. 
 
7.3 Reasons for late initiation of ART (study III) 
 
From this study we identified three overarching themes related to reasons for very late ART 
initiation among HIV-positive persons aware of their HIV status: 1. Weak health systems 
hindering timely initiation of ART, categorised as “ARV stock-outs”; “inadequate pre-ARV care”; 
and “lack of staff confidentiality”, 2. HIV/AIDS-related stigma hindering timely ART access, 
categorised as “HIV/AIDS-related stigma” and “lack of social support”, and 3. 
individual/community perceptions/misconceptions hindering timely initiation of ART, categorised 
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7.3.1 Health system barriers to timely initiation of ART 
ARV stock-outs 
The late initiators often reported that the inadequate supply or total lack of ARVs at the health 
facilities was a major demotivating factor, deterring new ART clients. Many witnessed that some 
eligible clients who were willing to start ART on time sometimes had to wait for months due to 
stock-outs of ARVs at the ART centres, making them feel discouraged and instead resorting to 
local herbs and traditional medicine: 
 
“Many times there are no ARVs at the centre. Some clients go and they are told they are ready for 
ARVs but they cannot start because the drugs are not there. We even wait for two to three months 
when the ARVs are not there. So this is discouraging.” (Male (44), late initiator) 
 
“Anyway, sometimes the centres have no ARVs and I think this discourages some new clients who 
are ready to begin. For me I was lucky after counselling for ARVs the drugs were there, but I know 
some friends I took to the clinic to start ART and there were no drugs.” (Female (41), timely 
initiator) 
 
The inadequate supply of ARVs was echoed by community members in the FGDs, who reported 
that their relatives sometimes had been unable to start ART because there were no drugs available 
at the clinics: 
 
“Maybe the problems of the Global Fund led to this, but the reality is we are sometimes told there 
are no ARVs and staffs have to borrow here and there. That is also a big problem,” (Female 
informant, FGD) 
 
Inadequate pre-ARV care 
Those who are diagnosed with HIV and are not yet eligible for ART due to good immune status 
are encouraged to go for routine monitoring of their immune status, i.e. pre-ARV care, in order to 
start ART on time before becoming symptomatic. Loss to follow-up during pre-ARV care was 
found to be crucial for late ART initiation. Many timely initiators had been under some kind of 
pre-ARV care which enabled them to be routinely monitored, and started on ART on time: 
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“Well me after testing in 2005 we were told to come every three months, we used to come and 
they examine us, they even took my CD4 three times in two years, so it really helped me to be 
captured on time.” (Male (33), timely initiator) 
 
Conversely, many late ART initiators had not attended pre-ARV care or had sought care very late 
in the disease process, leading to delayed HIV diagnosis and late ART initiation: 
  
“Anyway, me, the problem really is because I went to the hospital late. I was first deceived that I 
had been bewitched so I delayed to come. I think it was my fault. Actually our friends who went 
early in their illness started ARVs on time, and by the way they look very good.” (Male (35), late 
initiator) 
 
Lack of confidentiality 
Perceived lack of trust in some health workers was often mentioned by PLHIV as an important 
barrier to timely initiation of ART. Some late initiators reported knowledge of health staff 
sometimes discussing clients’ HIV status in public, and stated that this was the main reason for 
them and other clients avoiding seeking care at the HIV clinics: 
 
“Anyway like me, I had sworn not to go to the hospital because I hear the staffs are rude and they 
keep pointing at you in public as someone on drugs which is bad, but later I went because I had 
nothing to do.” (Female (24), late initiator) 
 
“The other problem is rumour-mongering by the staff. They talk about us in public telling people 
that we are on drugs so sometimes we fear to go there to keep our illnesses confidential.” (Male 
(35), late initiator) 
 
7.3.2 HIV/AIDS-related stigma and lack of social support inhibiting timely initiation of 
ART 
HIV/AIDS-related stigma 
HIV/AIDS-related stigma was found to have a major effect on seeking or accessing ART services 
on time. Some late initiators avoided any association with the ART clinic, since the public knew it 
was for PLHIV only. Others feared the negative perceptions associated with HIV/AIDS in the 
community. One account of a person living with HIV/AIDS described how they were coded by 
the community as the “walking dead”:  
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“You know, once people see you at the ART clinic they will obviously know you have AIDS, yet 
some of us don’t want people to know for fear of discrimination. So sometimes it is better to keep 
away to remain with your respect.” (Male (25), late initiator) 
 
“People point at you that you are a walking dead body, so naturally you fear to go. There is even 
one person who had all the signs of AIDS and l advised him to go and start treatment, but he 
feared to go and ended up dying.” (Male (35), late initiator) 
 
Lack of social support 
Social support from the immediate family or the community in general was also vital for timely or 
late ART initiation. Some late initiators completely lacked a social network that could support 
them financially or in their decision-making for seeking early care: 
 
“Like me, I don’t have support at all. Even my husband who should have helped me just accuses 
me of being a devil, a prostitute, and refuses to give me money to seek care. He says I brought the 
disease.” (Female (39), late initiator) 
 
In contrast, some timely initiators reported that the social support they had received from their 
immediate family had helped them seek services in time for ART: 
 
“Well for me my wife was very supportive. Even my brother they really encouraged me to seek 
help early after losing weight, so we went and my CD4 was 196, then I started ART.” (Male (42), 
timely initiator) 
 
7.3.3 Individual/community perceptions/misconceptions hindering timely initiation of 
ART 
Symbols of death 
Interviews revealed serious misconceptions about ARVs. Some late initiators perceived ARVs as 
drugs designed to kill, and thought that the Government used a particular type of ARVs labelled 
with a hoe and spade (a symbol of a grave) to kill PLHIV at a certain point in time after treatment 
started: 
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“Also we knew the Government wants to reduce on the population. After some time they give you 
drugs with a hoe and spade (sign of a grave) to kill us. So it’s better not to take the drugs. Me I 
came later because I had lost hope.” (Female (31), late initiator) 
 
“It took me time to go for ARVs because people say that if you take ARVs for some time, at a 
certain point the workers give you those that are marked with a hoe and spade (symbol of death) 
and when that happens you know you are finished.” (Male (25), late initiator) 
 
“They cause cancer and infertility” 
Apart from the perception that ARVs were drugs designed to kill, ARVs were also perceived to 
make PLHIV infertile or impotent, or predisposed to cancer. Many also believed that ARV drugs 
only give a brief life extension, since some people were known to have died shortly after ARV 
initiation. These misconceptions deterred many of those who had tested positive from seeking 
ART services in time: 
 
“Also, our experience is that these drugs cause cancer and they make people infertile. Others 
when they take them they live for a shorter period and then die, which is very discouraging.” 
(Female informant, FGD) 
 
7.4 Assessment of crucial risk factors for very late initiation of ART (study IV) 
 
This study was an unmatched case-control study. A total of 354 clients (152 cases initiating ART 
very late at a CD4 count of <50 cells/µl and 202 control subjects initiating ART late at a CD4 
count of 50-200 cells/µl) were interviewed for the study. The mean ages of the respondents were 
38.0 and 41.4 years for the cases and controls respectively. The majority of both cases (82%) and 
controls (61%) were female. More cases (80.5%) than controls (59.1%) were unmarried and 
84.5% of the very late initiators were subsistence farmers compared to only 40.9% among the 
controls. The majority of cases (70.2%) and none of the controls reported having experienced 
ARV stock-outs (Table 9). 
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Table 9. Univariate analysis of explanatory variables for ART initiation in Iganga, eastern Uganda (N=354). 
 
Characteristics CD4 <50 cells/µl (n=152)             CD4 50-200 cells/µl (n=202)  
  No. (%) No. (%) 
Sex   
     Male 28 (18.4) 78 (38.7) 
     Female 124 (81.6) 124 (61.3) 
Mean Age  38.0 (SD=8.8) 41.4 (SD=8.9) 
Education   
     Well educated (secondary +) 54 (35.5) 178 (88.1) 
     Low educated (primary) 98 (64.5) 24 (11.9) 
Marital status   
     Married 30 (19.5) 82 (40.9) 
     Unmarried 122 (80.5) 120 (59.1) 
Occupation   
     Non-farmer 24 (15.8) 120 (59.1) 
     Subsistence farmer 128 (84.2) 82 (40.9) 
Distance (km) to health facility (mean)  17.9 (SD=14.6) 14.6 (SD=15.2) 
ARV supplies experienced by patients   
     Stock-outs 107 (70.2) 00 (00.0) 
     No stock-outs 45 (29.8) 202 (100.0) 
Confidence in staff   
     Present 00 (00.0) 202 (100.0) 
     Absent 152 (100.0) 00 (00.0) 
Family support   
     Available 28 (18.4) 122 (60.4) 
     Not available 124 (81.6) 80 (39.6) 
Pre-ARV care   
     Attended 38 (25.0) 148 (73.3) 
     Not attended 114 (75.0) 54 (26.7) 
Traditional/spiritual care-seeking before 
ART   
     No 46 (30.3) 178 (88.1) 
     Yes 106 (69.7) 24 (11.9) 
 
 
Client-reported barriers to timely initiation of ART included mainly ARV stock-outs, competition 
from traditional healers, inadequate pre-ARV care and lack of family support, as reported by the 
very late initiators (Figure 7). 
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Figure 7.  Client-reported barriers to timely initiation of ART  in Iganga district. 
  
Other barriers for timely initiation of ART were personal characteristics such as being male, being 
a subsistence farmer or being younger. Very late initiators reported seeking care from 
traditional/spiritual healers because they perceived the healers as being accessible, nearer, less 




Figure 8. Client reasons for visiting traditional/spiritual healers before seeking ART care in Iganga district, 
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The bivariate analysis established that very late initiation of ART was a function of both 
individual/community-related factors as well as important health system-related factors. 
 
7.4.1 Individual/community-related factors 
Females were three times more likely to initiate ART very late compared to males (OR 2.8; 1.7-
4.6). Older clients had a lower risk of initiating ART very late compared to young clients (OR 
0.9; 95% CI 0.8-0.9). Low educated clients were almost 14 times more likely to initiate ART very 
late compared to clients who were well educated (OR 13.5; 95% CI 7.8-23.1). Clients who were 
unmarried were five times more likely to initiate ART very late compared to those who were 
married (OR 5.3; 95% CI 3.2-8.6). Subsistence farmers were eight times more likely to initiate 
ART very late compared to non-farmers (OR 7.8; 95% CI 4.7-13.1). Clients who lacked family 
support were seven times more likely to initiate ART very late compared to those who had family 
support (OR 6.7; 95% CI 4.1-11.1) (Table 10). 
 
7.4.2 Health system-related factors 
Clients who had reportedly not attended pre-ARV care were eight times more likely to initiate 
ART very late compared to those who had attended pre-ARV care (OR 8.2; 95% CI 5.1-13.3). In 
addition, clients who had reportedly sought care from traditional/spiritual healers before seeking 
formal ART care were 17 times more likely to initiate ART very late compared to those who did 
not seek prior traditional/spiritual care (OR 17.1; 95% CI 9.1-29.6) (Table 10).  
 
The variables that remained significantly associated with very late ART initiation in the 
multivariate analysis included being female (adjusted OR (AOR) 0.4; 95% CI 0.2-0.8), increase in 
age as a continuous variable (AOR 0.9; 95% CI 0.8-0.9), and living nearer the health facility 
(AOR 0.1; 95% CI 0.1-0.5), all of which were protective against very late ART initiation. The 
others were subsistence farming (AOR 6.3; 95% CI 3.1-13.0), lack of family support (AOR 3.3; 
95% CI 1.6-6.6), lack of pre-ARV care (AOR 4.6; 95% CI 2.3-9.3), and having sought previous 
care from traditional/spiritual healers for AIDS-related symptoms (AOR 7.8; 95% CI 3.7-16.4) 
(Table 10).  
  59  








     
Variable p value Crude OR (95% CI) p value AOR (95% CI) 
Sex     
     Male  1  1 
     Female <0.001 2.8 (1.7 - 4.6) 0.010 0.4 (0.2 - 0.8) 
Age (continuous)* 0.001 0.9 (0.8 - 0.9) 0.001 0.9 (0.8 - 0.9)  
Education     
     Well educated (secondary +)  1  1 
     Low educated (primary) <0.001 13.5 (7.8 – 23.1) 0.080 2.2 (0.9-5.1) 
Marital status     
     Married  1  1 
     Unmarried <0.001 5.3 (3.2 - 8.6) 0.120 1.8 (0.8 -3.7) 
Occupation*     
     Non-farmer  1  1 
     Subsistence farmer <0.001 7.8 (4.7 - 13.1) <0.001 6.3 (3.1-13.0)  
Distance to health facility (km)*     
        1-10  1   
      11-20      0.220 1.4 (0.8-2.5)   <0.001 0.1 (0.1-0.5) 
      21-30      0.010 2.3 (1.2-4.3)     0.001 0.1 (0.0-0.4) 
      31-65      0.060 1.8 (1.0-3.2)     0.024 0.3 (0.1-0.8) 
Family support*     
     Available  1  1 
     Not available <0.001 6.7 (4.1 - 11.1) 0.001 3.3 (1.6 - 6.6)  
Pre-ARV care*     
     Attended  1  1 
     Not attended <0.001 8.2 (5.1 - 13.3) <0.001 4.6 (2.3 - 9.3)  
Traditional/spiritual  
care-seeking before ART*   
     No  1  1 
     Yes <0.001 17.1 (9.1 - 29.6) <0.001 7.8 (3.7 - 16.4)  
* Statistically significant at 5% level. 
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8.0 DISCUSSION 
8.1 Discussion of main findings 
 
In this thesis we highlight that loss to follow-up of PLHIV in transit from HIV counselling and 
testing to pre-ARV care and subsequent initiation of ART (Figure 2) is not just a function of the will 
of the PLHIV, but a complexity of intertwined factors ranging from a deficient health system to 
individual/community misconceptions about HIV care. We also demonstrate that a low-cost 
intervention - extended counselling through use of available staff with basic training in counselling 
skills - combined with home visits by community network support agents, can improve uptake of pre-
ARV care and status disclosure (paper II), which may improve timely initiation of ART. The main 
health system factors involved include inadequate post-test counseling, lack of pre-ARV care for 
newly screened PLHIV, competition from traditional and spiritual healers, ARV stock-outs and 
perceived lack of staff confidentiality (papers I, III and IV). The individual/community perceptions or 
misconceptions that hinder regular pre-ARV care or timely initiation of ART include stigma and 
associated lack of family/social support, gender inequality (particularly affecting women) and 
misconceptions about ARVs (papers I, III and IV). Adequate post-test counseling at the time of VCT 
and follow-up care that is accessible and affordable by the PLHIV (I, II) are thus central to uptake 
and retention of PLHIV under pre-ARV care. Retention of PLHIV under pre-ARV care (III, IV) is 
also vital for timely initiation of ART (Figure 2).  
 
In the socio ecological model, the will of the PLHIV to seek care falls under the individual level, the 
deficient health system falls under the organizational and public policy level, while community 
misconceptions about HIV care fall under the interpersonal, organizational and community levels. 
The low-cost intervention cuts accross all the levels of the model (Figure 1). The findings therefore 
illustrate the importance of the relationship between the person (PLHIV) and other levels of their 
environment (partner, family, community, social networks and health system goals and functions), in 
influencing access to HIV care and health-seeking behaviour (Figure 1). Therefore , enhancing 
uptake of pre-ARV care, minimising loss to follow-up of PLHIV and improving timely initiation of 
ART will require focus on several levels: the PLHIV, the deficient health system, the community and 
other social environmental factors to develop comprehensive interventions that systematically target 
mechanisms of desired change at each level of influence (McMurray, 2006, McLeroy et al., 1988, 
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Stokols et al., 1996, Sallis JF and Owen N, 2002, Sallis and Glanz, 2006, Fleury and Lee, 2006, 
Moore, 2001).  
8.1.1 Health systems-related factors 
 
Inadequate post-test counselling 
 
Inadequate post-test counselling was one of the reasons for loss to follow-up of PLHIV during pre-
ARV care (paper I). Newly screened PLHIV were not given adequate information about the 
importance of pre-ARV care or the dangers of dropping out of pre-ARV care. The PLHIV expressed 
a lack of awareness of why and when they should return for pre-ARV care, which is likely to have 
contributed to the high dropout rate during pre-ARV care (Figure 2). The staff in the clinic also 
confessed that because of the high workload, they did not have enough time to educate the newly 
screened PLHIV about the importance of regular pre-ARV care.  
 
The importance of counselling as a prerequisite for retention of PLHIV in HIV care programmes has 
been highlighted by other studies in Africa and Asia (Hardon et al., 2007, Chesney, 2000, Coetzee et 
al., 2004, Sanjobo et al., 2008). Much as the WHO provides standardised post-test counselling 
guidelines for PLHIV, in many low-income settings the quality and quantity of post-test counselling 
is poor, partly because the staff are overloaded or have not been trained in basic counselling skills 
(WHO/UNAIDS, 2005). Improving post-test counselling would necessitate the health system 
overcoming the challenge posed by staff workload or lack of counselling skills which fall under the 
organizational and public policy level of the SEM. This may help in enhancing awareness about the 
importance of regular pre-ARV care for the PLHIV (under the individual level of the SEM), and 
hence minimize those lost to follow-up. The SEM recognises that behaviour change is expected to be 
maximised when individuals are motivated and educated to make useful health choices (WHO, 1986, 
McMurray, 2006).  
 
Lack of pre-ARV care 
Lack of pre-ARV care was related to late ART initiation (papers III and IV). Regular attendance of 
pre-ARV care enhances routine assessment of a patient’s eligibility for treatment and hence timely 
ART initiation (Figure 2). As demonstrated by previous research from resource-poor high-prevalence 
settings in Uganda, South Africa and Asia, the finding highlights the importance of early HIV 
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diagnosis, adequate post-test counselling and follow-up for PLHIV in pre-ARV care to ensure timely 
initiation of ART (Chesney, 2000, Sanjobo et al., 2008, USAID, 2009, Lawn et al., 2010, Kigozi et 
al., 2009).The lack of pre-ARV care could be attributed to late presentation/late diagnosis and hence 
failure to benefit from the advantages of early diagnosis such as post-test counselling and routine 
monitoring of eligibility for ART (Losina et al., 2010, Long, 2008).  
 
Lack of pre-ARV care could also be related to factors that go beyond the individual will of the 
PLHIV (individual level of the SEM) - to the health system and community deficiencies in general 
(organisational, community and public policy levels of the SEM). Long distance to the health facility, 
transport costs, hunger, waiting time and stigma have, for example, been established as important 
barriers to access and adherence to HIV care in resource-poor settings (Hardon et al., 2007, Maskew 
et al., 2007). The health system therefore needs to adopt comprehensive HIV care approaches that go 
beyond the individual will to take an HIV test and attend pre-ARV care to also address associated 
gaps in the community and the health system itself. Comprehensive home- based HIV care from VCT 
to ART which addresses some of these gaps has, for example, been found to improve access to and 
retention of PLHIV in HIV care programmes, the HIV-related stigma and involved high costs 
notwithstanding (Weidle Paul J et al., 2006, Mukherjee et al., 2006). 
 
The role of low-cost interventions (II) 
Study II demonstrates that if newly screened PLHIV receive specialised counselling by staff who 
have received low-cost training in basic counselling skills, combined with home visits by community 
support agents, they are up to 80% more likely to take up pre-ARV care (paper II). The study further 
indicates that extended counselling may also help clients overcome other barriers to comprehensive 
HIV care in resource-poor settings (such as high transport costs), as well as enhance social support by 
encouraging status disclosure. The finding meets the WHO recommendation for effective 
interventions that are simple and relatively inexpensive to improve the quality of life of PLHIV, 
prevent further transmission of HIV, delay progression of HIV disease and prevent mortality by 
increasing access to care through health facilities and community outreaches (Nakanjako et al., 2009, 
WHO et al., 2008). 
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Community support agents (who fall under the interpersonal, organizational and community levels of 
the SEM), may thus be used to supplement the efforts of the already overloaded staff at ART clinics 
and make the health system more efficient in providing pre-ARV care to the PLHIV. The 
intervention is therefore likely to create the impetus for routine pre-ARV care for the poor and most 
vulnerable PLHIV and subsequently ensure timely access to ART (Figure 2). 
 
The direct financial cost for the training in basic counselling skills was only US $20 per staff 
member, a sum that should be comparable in other rural contexts in SSA. In similar settings that are 
able to mobilise volunteer community support agents, such an intervention would therefore probably 
be feasible. The authorities would, however, need to address other important system deficiencies such 
as stock-outs of HIV testing kits and cotrimoxazole, and the poor staff attitudes towards clients that 
are common in similar settings (MOH, 2009).  
 
Competition from traditional/spiritual healers  
Competition from traditional/spiritual healers was related to loss in transit of PLHIV during pre-ARV 
care (paper I), and is a crucial risk factor for very late initiation of ART (paper IV). The healers 
undermined formal HIV care as they provided alternative and competing HIV care services. Many 
ART-eligible clients reportedly sought care late (Figure 2) because they had been delayed by first 
seeking traditional/spiritual healing, which they perceived as being more accessible, cheaper, holistic 
and of better quality compared to the established ART centres (paper IV).  
 
Other studies indicate that the influence of such healers on people’s health-seeking behaviour is not 
unique to Iganga but also many other resource-poor settings (WHO et al., 2008, Taylor et al., 2008, 
Burnett et al., 1999, Baguma, 1996, Kaboru, 2008, Ritzenthaler, 2005, Homsy and King, 1996, 
Ochai, 2008, Tate et al., 2010, Kusimba et al., 2003). Available evidence indicates that four out of 
every five PLHIV in the rural developing world visit and use traditional/spiritual healing (Frimpong 
JY and Oppong, 2004, Prometra, 2008, UNAIDS, 2000).  
 
Studies by the (WHO, 2004, Myron, 2002, Robert, 2005) also show significant evidence that many 
PLHIV seek spiritual healing at all stages of the HIV/AIDS cycle from VCT to ART. Although many 
traditional and other complementary healers in Uganda remain unaffiliated to the formal health 
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system, approximately 60% of Uganda’s population seeks care from them before visiting the formal 
health sector (MOH, 2009). The healers have been confirmed to provide client-centred, personalised 
health care that is culturally or spiritually appropriate, holistic and tailored to meet the needs of and 
expectations of the patients (UNAIDS, 2000). Because traditional healers are culturally/spiritually 
close to the patients, they easily communicate to patients about disease and other related social issues, 
which is an important factor in the treatment of STIs (UNAIDS, 2000).  
 
In the SEM, traditional/spiritual healers fall under the organizational and community levels. Since 
they seem to have a big influence on health-seeking behaviour for PLHIV, policy makers could 
consider integrating them into comprehensive HIV care at the public policy level of the SEM as well. 
This may be achieved through sensitising and support-supervising the healers to provide some HIV 
care services, like distributing cotrimoxazole to PLHIV. Such collaboration has been found useful in 
counselling and herbal research in Uganda and Zambia (Burnett et al., 1999, Kaboru, 2008). 
However, adequate training and supervision of the healers needs to be emphasised to ensure that 
quality of care is not compromised.  
 
Timely ART initiation could be improved by making ART services more affordable, accessible and 
user-friendly through peripheral units and trained, supervised lay workers, so that the services are 
more attractive than traditional/spiritual healers. Such interventions have been found effective in 
clinical studies in Africa, where ART delivery models for nurses and non-clinical staff aimed at 
reducing the workload of physicians and treatment and monitoring delivered through peripheral 
health centres or through home visits have achieved better adherence and been more cost-effective 
than ART delivery at hospitals (Jaffar et al., 2005, Jaffar, 2009).  
 
ARV stock-outs 
A major health system-related factor for very late initiation of ART was the irregular supply of ARVs 
(papers III and IV). At times when ARVs were out of stock, some clients who had been counselled to 
start ART reportedly had to wait for a long time before they could start treatment. The demotivation 
caused by lack of ARVs could have been a main gateway for many PLHIV getting lost in transition 
before actually initiating ART (Figure 2). This finding supports other reports on ART-eligible clients 
  65  
failing to access ARVs or doing so too late due to stock-outs in Uganda (Nakkazi, 2009, Nakanjako 
et al., 2009, Hasunira and Muhinda, 2009, Avert, 2010, Jirair, 2010).  
 
The stock-outs of ARVs could have been due to an inefficient supply and procurement chain and/or a 
poor data management system that undermined forecasting the quantities of drugs required. ARV 
stock-outs could also partly have been due to shortfalls in funding for procuring the drugs, which is a 
common occurrence in Uganda due to shortfalls in health care financing for the public health sector 
(MOH, 2009).  
 
Stock-outs of essential drugs due to insufficient supply chains and shared responsibilities between 
key actors that may be difficult to influence at facility level alone are common in SSA 
(UNAIDS/WHO, 2005, Kiwanuka et al., 2008). There is need, however, to ensure procurement 
planning at facility, district and national level (figure 1) for all drugs and supplies needed to improve 
comprehensive HIV care. Ensuring availability of ARVs to communities at all times is vital for 
encouraging service utilisation (WHO, 2003c). Timely and appropriate provision of drugs as a way of 
improving quality of care was also found significant in sociocultural studies to explain timely and 
appropriate use of health facilities for febrile illnesses in Tanzania and Malawi (Dillip et al., 2009, 
Chibwana et al., 2009). 
 
Lack of staff confidentiality 
Perceived lack of confidentiality of the staff by the PLHIV was mentioned as a barrier to accepting 
and seeking HIV care services (paper III). Confidentiality is a crucial aspect in all sorts of patient 
management, but in particular for PLHIV. Many PLHIV have not even disclosed to their partners, 
social networks or employers that they are HIV-positive or on treatment because of the stigma 
associated with ARVs, which may be as strong as the stigma associated with the actual infection. Our 
finding is supported by other studies from Uganda, Ethiopia and Pakistan, where perceived provider 
confidentiality was an important factor for determining health-seeking behaviour and drug adherence 
(Gusdal et al., 2009, Mbonye AK et al., 2009, Shaikh, 2008, Shaikh et al., 2008).  
 
If true, however, this perception raises major concerns regarding the ethical conduct of many health 
care providers and the serious effects of confidentiality breach on health-seeking behaviour of 
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PLHIV. Policy makers and providers therefore need to ensure that policy guidelines with regard to 
client privacy and confidentiality are disseminated and adhered to by the attendant staff.  
 
Social mobilisation for PLHIV and the community in general through the local media or local leaders 
should be done to assure clients that their illnesses will be kept as confidential as possible. The newly 
screened PLHIV also need reassurance at the time of VCT that their HIV sero status or treatment will 
not be disclosed to anyone without their consent. Such interventions that go beyond the individual 
PLHIV but also include the health care delivery system and their environment are likely to be 
successful in improving provision and health seeking for comprehensive HIV care (DiClemente et 
al., 2004; DiClemente et al., 2005; Campbell et al., 2007; Sallis & Glanz, 2006; Sallis & Owen, 
2002; CARE, 2010). 
 
8.1.2 Individual/community factors hindering timely initiation of ART  
 
Lack of social support, gender inequalities and misconceptions about ARVs were found to be barriers 
to timely initiation of ART in this study. 
 
Lack of social support 
PLHIV are faced with a broad array of needs related not only to treatment of HIV, but also 
emotional, material, nutritional, financial, spiritual and psychosocial support. In this study, lack of 
social support was reported as a barrier to timely initiation of ART and associated with very late 
initiation of ART (papers III and IV). The significance of social support as a prerequisite for 
appropriate HIV care has been reported by other studies in South Africa, Zambia, Malawi, India and 
Brazil (Carvalho et al., 2007, Birbeck et al., 2009, Bwirire et al., 2008, Feucht et al., 2007, Makoae et 
al., 2008, USAID, 2009).  
 
Social support helps in accessing ART services, and understanding behavioural and routine changes 
in the schedule of PLHIV such as monthly or quarterly visits to the ART centre for pre-ARV care or 
ARVs. It also discourages HIV/AIDS-related stigma (paper III). On the other hand, inadequate social 
support predisposes PLHIV to, among others, unemployment, poverty, and lack of awareness of or 
access to vital information and communication about the care. Inadequate social capital has been 
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established as a vital predictor for late or poor health-seeking behaviour by other studies in low- and 
medium-income countries (Kigozi et al., 2009, Krawczyk et al., 2006, Diero et al., 2006, Severe et 
al., 2005, Wood et al., 2003, Bakeera et al., 2009, Bakeera et al., 2010, Ahmed  F et al., 2005).  
 
The social support may be provided by the intimate partners of PLHIV, the immediate family, close 
friends, relatives, employers, spiritual leaders or other social networks at the interpersonal and 
organizational levels of the SEM. Thus, while the provision of free ARVs has increased rapidly in 
Uganda, the Ugandan Government and global funding agencies need to address the unmet need for 
social support to PLHIV proportionately in order to positively influence timely and appropriate HIV 
care. Indeed, the Government of Uganda and its partners has made social support a thematic area for 
improving comprehensive HIV care in the country in its National HIV & AIDS Strategic Plan 
2007/8-2011/12 (UAC, 2007, UAC, 2010, URCS, 2008, Population-Council., 2010).  
 
Enhancing the social support for PLHIV will require focus on both the individual and socio- 
environmental factors to develop comprehensive interventions that systematically target mechanisms 
of change at each level of influence (McMurray, 2006; Stokols et al., 1996; Fleury & Lee, 2006; 
Sallis & Owen, 2002; McLeroy et al., 1988; Sallis & Glanz, 2006). Several authorities also 
emphasise that the concept of seeking and accessing health care must be a shared responsibility 
between individual, organisational, community and public policy structures (Shaikh et al., 2008, 
Moore., 2001). 
 
Misconceptions about ARVs 
Misconceptions/negative perceptions about ARVs, container labels and PLHIV were found to be 
deterrent to timely ART initiation (paper III). Some PLHIV negatively perceived ARVs as drugs 
designed by Government to kill and control population growth, or causing cancer or infertility.  
Negative perceptions and dangerous misconceptions have been identified as barriers to HIV 
diagnosis and ARV treatment by other studies in Uganda, Tanzania and other resource-poor settings    
(Atuyambe et al., 2008, Nicholson et al., 2006, Micek et al., 2009, Chomat et al., 2009, Ezekiel et al., 
2008, Ezekiel et al., 2009).  
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Previous studies from Africa, South America and Asia have also established that misconceptions 
about drugs or other care are vital in terms of health-seeking behaviour (Ezekiel et al., 2009, Bonjour 
et al., 2008, Banerjee and Mattle, 2005). The misconceptions about ARVs could have been a function 
of lack of knowledge and awareness about HIV or HIV care-seeking concepts and the branding of 
ARV drug containers (Agnew-Blais et al., 2008).  
 
Thus although there is apparent knowledge about HIV and ART in Uganda, many people - especially 
in rural settings - still have negative misconceptions about several elements of comprehensive HIV 
care (MOH, 2006). Policy and practice should therefore be driven towards sending out messages that 
address the misconceptions about ARVs to enhance acceptance of ART. Great care must be taken to 
pilot the disseminated information, if possible in all the local languages, to make sure it is accurate 
and to avoid misinterpretation.  
 
Gender inequality 
Gender inequality was reported as a reason for loss to follow-up of PLHIV during pre-ARV care 
(paper I). The case of a man denying his four wives access to pre-ARV services gives a contextual 
image of what may happen in similar family set-ups. Studies in Africa and Asia have also found that 
women cannot access STI services like VCT because of financial constraints, lack of information and 
lack of decision-making powers as to when and where to seek the care (WHO, 2003b, Voeten et al., 
2004, Manhart et al., 2000). Other studies have also established that women are disadvantaged 
compared to men in accessing health care in general (Turmen, 2003, Wingood et al., 2007, Skinner 
and Mfecane, 2004, Mrisho et al., 2009, USAID, 2009).   
 
In paper IV, however, women were 60% less likely to start ART very late compared to men after 
adjusting for other confounders. We deliberately excluded females diagnosed with HIV/AIDS early 
due to pregnancy and initiated on ART through the PMTCT programme so that we could look at all 
other women. The finding can probably be explained by the stronger stigma and denial seen among 
men in relation to AIDS-related symptoms in resource-poor settings, as reported elsewhere (Larsson 
et al., 2009). The socio-ecological context of the finding is that policies that address men’s stigma 
and women’s disadvantages in decision making and care seeking for HIV care and other health-
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related problems need to be emphasised at all levels of the ecological tree, from the personal and 
interpersonal to organisational and community perspectives (Moore, 2001). 
 
8.2 Methodological considerations 
 
8.2.1 Papers I and III 
For papers I and III (qualitative papers) the research team tried to take all appropriate measures to 
ensure that the aims for which the two studies were conducted were achieved. The research team was 
multidisciplinary and included a public health physician (LM) who has managed HIV patients in the 
pre-ARV and ART clinics for at least 10 years. The other (XN) was a social scientist with a lot of 
experience in carrying out qualitative research with regard to HIV care in the research setting. The 
research assistants were native to the area, understood the local language and had been involved in 
conducting qualitative research in the study setting. The team was thus well prepared in 
understanding the contextual aspects of the topics under study (Dahlgren et al., 2004).  
 
The team collected data from a variety of sources, including staff who worked at the clinics, the 
PLHIV themselves and their relatives or caretakers. We also triangulated our data collection methods 
(KII, FGDs and IDIs), which helped us to check for consistency and contradictions inside and across 
the groups and interviewees (Rice P L and Ezzy, 1999, Berg, 2001). During data collection the team 
spent long periods of time with the interviewees in the field which, enabled us to understand the 
reality of our respondents. LM and XN initially coded the data independently and later sat to agree on 
the coding. The team also presented the scripts and agreed coding to peers (PG, TNM, SP, AME and 
FWM) who were not part of the data collection process to generate consensus on the coding process 
(Dahlgren et al., 2004). We therefore feel that the content analysis employed for these studies has 
contributed appropriate in-depth analysis for the purpose of the studies.  
 
There were, however, some shortcomings. We did not observe how post-test counselling is conducted 
at the units. This could have helped us assess the quality of the counselling and its contextual 
relationship with drop-outs from pre-ARV care. Similarly, conducting FGDs with friends, relatives or 
caretakers of PLHIV instead of the PLHIV themselves was also a limitation, since it generated 
collateral information which sometimes needed validation. However, the collateral information from 
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the caretakers helped us understand the sociodynamic and contextual issues related to loss to follow-
up of PLHIV under pre-ARV care and late initiation of ART. 
 
 
8.2.2 Papers II and IV 
Randomisation and masking 
In paper II the description of the intervention by background characteristics shows that randomisation 
of the study participants worked well, and that the association between the intervention and the 
outcome variable (uptake of pre-ARV care) may not have been affected by participant assignment 
bias. All the staff members who conducted the counselling at the different centres were from the 
same units and had worked together in these units for a long time; thus complete decontamination 
between staff was hard to ensure, but genuine efforts were made during pre-trial training to inform 
them about the importance of avoiding discussing the intervention. It was also impossible to entirely 
ensure that the participants did not share information about the trial between themselves, although 
this is unlikely given the sensitivity of the topic and the high stigma still associated with HIV in the 
community (Roura et al., 2009, UAC, 2007). 
  
Follow-up and unpacking the intervention 
The intervention did not involve following up of the community support agents. It was therefore 
difficult to ascertain the quality and quantity of counselling they provided to the participants during 
follow-up visits in their homes.  It was equally hard to ascertain whether it was the initial post-test 
counselling provided by the staff at the unit in the intervention arm, and/or the follow-up counselling 
provided by the community support agents that encouraged participants to come back for pre-ARV 
care. Unpacking the intervention could thus be a subject for further research. 
 
Selection bias 
In paper IV the use of CD4 count as a measure for very late initiation of ART influences the 
interpretation of our results, because a low CD4 count does not automatically translate into late 
disease or symptomatic disease but varies somewhat among individuals. The decision to use CD4 
counts to classify case status as well as the low cut-off margins used was made to facilitate 
comparisons with other studies taking the current WHO classification of late presentation as a 
  71  
standard. The decision was also based on our clinical observations and other studies performed in 
Uganda about the prognosis of very late ART initiators. All adult clients on ART in the hospital who 
enrolled for ART during the study period (January 2005 - December 2009) were eligible for the 
study. Given that 40% of the clients initiated on ART in Iganga district between 2004 and 2009 had a 
CD4 cell count of <50 cells/µl and that the mean and median CD4 cell counts at initiation of ART for 
all clients were 122 and 126 cells/µl respectively (range 14 -198 cells/µl) (DHO, 2009), these 
margins made all clients initiated on ART during the study period eligible.  
 
The selection criteria excluded clients who could not afford to pay for a CD4 count at the time of 
ART initiation. This could have introduced a bias since only the richer, who could afford to pay, were 
selected. The influence of the bias is, however, unlikely to have affected the results since social 
support still emerged as a significant predictor for delayed ART initiation. The influence of the 
possible selection bias introduced by only including subjects alive at the time of study, often 
encountered when using retrospective real-life data, is impossible to determine, but is unlikely to 
have affected the results for the study since the risk factors such as stock-outs of ARVs for the dead 
clients are likely to have been the same. 
 
Recall bias 
In study IV (case-control) the respondents were asked questions related to several variables of the 
study that could have occurred at most five years prior. Recall bias generated by this phenomenon is, 
however, unlikely to have played any major role in this study since the identified risk factors like 
availability of drugs did not require any detailed retrospective recall that could be assumed to differ 
between cases and controls subject in this study.   
 
Sampling bias 
Some CIs in study IV are wide due to the fairly small sample size. However, the sampled data still 
allowed us to identify a number of statistically significant predictors for very late initiation of ART 
with enough precision to lay the groundwork for the necessary health systems and policy 
interventions needed to encourage earlier ART initiation. 
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Generalisability and Transferability 
The findings of studies II and IV did not include pediatric PLHIV, nor were women identified as 
HIV+ in PMTCT included in study IV, which limits generalisability to these groups. Quantitative 
results could be transferred to other rural Ugandan districts and other SSA settings where the health 
system structures, resource-level and community settings are similar to those of Iganga district. While 
Iganga district is relatively densely populated, the identified barriers to care may be even stronger in 
more sparsely populated settings.  
For the qualitative studies (I and III), the transferability of our findings to populations and contexts 
beyond our research context may be more limited. We have, however, tried to give a thick description 
of the research and analysis process to enable judgements by other readers on how transferable our 
findings are to other comparable contexts (Dahlgren et al., 2004).  
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9.0 CONCLUSIONS 
 
 Inadequate post-test counselling due to staff workload and lack of incentive to emphasise the 
importance of pre-ARV care to newly screened PLHIV hinders uptake and adherence to 
regular pre-ARV care for non-ART-eligible PLHIV. (I) 
 
 Extended counselling by staff with short-term training in basic counselling skills combined 
with home visits by volunteer community network support agents for ongoing counselling is 
associated with uptake of regular pre-ARV care and status disclosure for PLHIV. (II) 
 
 Competition from the influential traditional/spiritual healers, who are perceived by the PLHIV 
as being accessible, friendly, cheaper, holistic and to offer better-quality services than 
Government facilities, is a barrier to regular pre-ARV care and timely initiation of ART. (I 
and III)  
 
 ARV stock-outs, inadequate or lack of pre-ARV care, lack of staff confidentiality, prevailing 
stigma and lack of social support, and misconceptions about ARVs or their package labels are 
barriers to timely initiation of ART. (III) 
 
 Lack of pre-ARV care, lack of family/social support, competition from traditional/spiritual 
healers and ARV stock-outs are crucial risk factors which are significantly associated with 
very late initiation of ART. (IV) 
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10.0 POLICY IMPLICATIONS 
  
Findings from the studies outlined in this thesis have implications for policy on uptake of pre-ARV 
care, loss to follow-up of PLHIV during pre-ARV care, and timely initiation of ART. The basic 
foundation is that there are already existing policies at national and international level (Uganda 
National Health Policy, Health Sector Strategic Plan II, the National AIDS Policy and UNAIDS 
policies) to address the system deficiencies and individual/community factors that influence loss to 
follow-up during pre-ARV care and timely initiation of ART. The inferences of this thesis are a 
contemplation of how we can get the policies into practice in the context of our findings. 
 
Practice should highlight recruitment of counsellors or training of staff in the pre-ARV/ART clinic in 
counselling skills to address inadequate post-test counselling for newly screened PLHIV. This should 
be complemented by home visits by the network support agents for ongoing counselling to PLHIV. 
This practice will encourage uptake and reduce loss to follow-up of PLHIV in HIV care, and enhance 
status disclosure and family social support in the long run.  
 
The influential and accessible spiritual/traditional healers should be considered for sensitisation and 
integration into pre-ARV care, with close monitoring and support supervision by the government. 
Such integration has registered some success in HIV counselling and herbal research with regard to 
managing PLHIV in Uganda and Zambia.  
 
Community network support agents could be trained, supported and supervised for doorstep 
cotrimoxazole distribution to PLHIV in their homes, as is done with the home-based management of 
fever. This would reduce transport costs and waiting time for PLHIV. However, the authorities will 
need to address other important system deficiencies such as stock-outs of HIV testing kits and 
cotrimoxazole, as well as staff attitudes towards pre-ARV care and the perceived lack of staff 
confidentiality. 
 
There is a need to ensure that all new HIV clients access regular pre-ARV care for routine monitoring 
in order to start ART on time. Pre-ARV care should be supplemented with economically viable, 
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established social support networks for PLHIV, such as post-test clubs with income-generating 
activities targeting especially the poor and most vulnerable PLHIV.  
 
Policy makers and health care providers must also put more emphasis on strategic ARV procurement 
planning and the supply chain to prevent stock-outs through appropriate coordination and control of 
the different stakeholders at national and subnational levels. This could be supplemented by taking 
ARVs closer to the community to cut access costs, as has been established by studies in Uganda 
where ART was successfully delivered locally through appropriate training and support supervision 
of lay workers and lower cadre staff.  Making ART services more affordable, accessible and user-
friendly through peripheral units could help to make ART centres/services more attractive than 
traditional healers.  
 
Authorities also need to send out media messages and information, education and communication 
materials that address resentment of PLHIV, self-stigma and misconceptions about ARVs and their 
branding, to enhance acceptability of ART by PLHIV.  Great care must, however, be taken to pilot 
the disseminated information, if possible in all the local languages, to make sure it is accurate and to 
avoid misinterpretation.  
 
Gender inequality, where women lack information about HIV and HIV care in general could be 
addressed by sensitising women about the importance of HCT and pre-ARV care through the local 
media and local leaders. Men also need to be sensitized against HIV stigma and the importance of 
early HIV diagnosis and care. 
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